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DESIGN, SYNTHESIS AND CHARACTERIZATION OF END-
FUNCTIONALIZED GLYCO-POLYMER FOR EFFICIENT 
PROTEOMIC ANALYSIS 
 
SATYA NANDANA NARLA 
 
ABSTRACT 
 
Carbohydrates, especially, cell surface carbohydrates act as receptors for a variety 
of ligands such as proteins and thereby play significant roles in physiological and 
pathological processes, including cellular recognition and communication, bacterial and 
viral infection, and tumor metastasis. As such, binding interactions of carbohydrates and 
proteins have provided a starting point for the development of concept of isolation and 
probing of proteins and cells in biological research and novel diagnostic agents as well as 
new therapeutic applications. In this thesis study, oriented and multivalent carbohydrate 
macromolecules were designed and developed based on a chain-end functionalized 
carbohydrate-containing polymer (glycopolymer) for efficient protein analysis. Firstly, 
O-cyanate chain-end functionalized glycopolymer was synthesized via cyanoxyl-
mediated free-radical polymerization (CMFRP) in one-pot fashion. This glycopolymer 
was tested for its oriented glyco-marcroligand formation and its glyco-affinity capturing 
and glycanarray application by combining O-cyanate chain-end functionalized 
glycopolymer with commercially available amine-functionalized silica gel and glass slide 
vi 
 
via isourea bond formation, respectively. In the second study we demonstrated a new 
type of glycan microarray, namely, oriented and density controlled glyco-macroligand 
microarray based on end-point immobilization of glycopolymer that was accompanied 
with boronic acid (BA) ligands in different sizes as detachable “temporary molecular 
spacers”. The spaced glycopolymer microarray showed enhanced lectin binding 
compared to non-spaced one.  Third, a chemoenzymatic synthesis of chain-end 
functionalized sialyllactose-containing glycopolymers with different linkages was 
performed and their oriented immobilization for glycoarray and SPR-based glyco-
biosensor applications were studied. Specifically, O-cyanate chain-end functionalized 
sialyllactose-containing glycopolymers were synthesized by enzymatic α2,3- and α2,6- 
sialylation of a lactose-containing glycopolymer and characterized by 
1
H NMR. They 
were printed onto amine-functionalized glass slides for glycoarray formation. Specific 
protein binding activity of the arrays were confirmed with α2,3- and α2,6-sialyl specific 
binding lectins together with inhibition assays. In addition, sialyllactose  glycopolymers 
were immobilized on amine-modified SPR chip to study the specific binding activity of 
lectins and influenza viral hemagglutinins (HA). These sialyloligo-macroligand 
derivatives combined with oriental and density controlled glycan array and SPR-based 
glyco-biosensor are closely to mimic 3D nature presentation of sialyloligosaccharides and 
will provide important high-throughput tools for virus diagnosis and potential anti-viral 
drug candidates screening application. 
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CHAPTER I 
 
INTRODUCTION 
 
 
1.1 Introduction 
     Carbohydrates envelop almost all living cell surfaces, mostly in the form of 
glycoconjugates such as glycoptoteins, glycolypids and proteoglycans. These 
carbohydrates on cell surface are playing significant roles in many biological processes, 
such as, cell-cell signaling,
1-2
 immune recognition events,
3
 pathogen host interaction,
4
 
tumor metastasis,
5
 tissue growth and repair,
6
 etc (Fig 1). Therefore, studying 
carbohydrate binding interaction has provided a starting point for understanding the 
molecular mechanisms that carbohydrate related and development of new therapies,
7
 
protein and cell isolation,
8
 and targeted drug and gene delivery
9
 concept in biomedical 
research and applications. It has been known that the carbohydrate-protein interactions 
are significantly enhanced by multivalent carbohydrate ligands referred as “cluster 
glycosidic effect”.10 In the past decades, variety multivalent carbohydrate ligands such as 
glycopolymers, namely polymers with carbohydrate pendent groups, have been 
2 
 
extensively explored for different applications.
14-22
 Moreover, it is accepted that synthetic 
glycopolymers mimic functions of naturally occurring polysaccharides
23-24
 and were 
employed for binding cell-surface receptors.
25
 The strength and selectivity of binding 
interactions between multivalently displayed carbohydrates and targets are likely to 
depend on the density and relative spatial arrangement of the carbohydrate residues of 
glycopolymers.
25
 Recently, the potential utility of glycopolymers in bio- and 
immunochemical assay, as biocapture reagents and for microarray applications has been 
demonstrated by the addition of functional anchor groups either as a pendant to the 
polymer backbone or at the chain end. Particularly, the chain-end groups of the polymer 
are the focus for bio-functionalization, as they allow for a direct one-to-one attachment
26-
27
 and also facilitate site specific
16
 and oriental immobilization on solid surface.
28
 This 
molecular recognition is especially exploited on surfaces for the development of 
biosensors, chip-based bioassay, or cell-adhesion studies
29
 as they mimic the three 
dimensional display of glycans on the cell surface.  
3 
 
 
Figure 1. Cell Surface Carbohydrates: protein–carbohydrate interactions at the cell 
surface mediating biological processes. 
 
1.2 Chain-end functionalized glycopolymers 
     Glycopolymers carrying pendant sugar moieties are either synthesized by direct 
polymerization of carbohydrate-containing monomers with protection group or without 
protection group, or by the post polymerization glyco-conjugation of synthetic 
polymers.
30 
The polymerization can be carried out by a range of polymerization 
techniques. This includes: free-radical polymerization (FRP),
31
 living anionic 
polymerization,
32
 ring-opening polymerization (ROP),
33
 ring opening metathesis 
polymerization (ROMP),
34
 cyanoxyl mediated free-radical polymerization (CMFRP),
35
 
4 
 
and controlled/living free-radical polymerization (CLRP) which, encompasses nitroxide 
mediated controlled free-radical polymerization (NMP),
36
 atom transfer radical 
polymerization (ATRP),
37
 reversible addition-fragmentation chain transfer (RAFT)
38
 
polymerization. During the past decade, various glycopolymers with diverse chain-end 
functional groups like aldehyde, azide, biotin, N-hydroxysuccinamide, malimide, 
pyridine disulfide, and O-cyanate have been synthesized for various applications. 
ROMP,
39-41
 CMFRP,
28, 42-43
 ATRP,
44-47
 and RAFT
48-52
 have been employed for the 
synthesis of chain-end functionalized glycopolymers. The syntheses and applications of 
the above stated chain-end functionalized glycopolymers was summarized as in Table 1. 
 
Table 1. Chain-end functionalized glycopolymers and their syntheses and biomedical 
applications 
Chain End Carbohydrate Synthesis Application Reference 
Fluorescein 3,6-O-disufo-Gal ROMP and post 
conjugation 
L-selectin binding on 
cell surface 
39 
COOH 3,6-O-disufo-Gal ROMP and post 
conjugation 
Surface immobilization 40 
Biotin Chondrotin Sulfate ROMP and post 
conjugation 
Surface Immobilization 41 
Biotin Lact CMFRP Surface immobilization 42 
Biotin, 
COOH, 
NH2, 
Hydrazide 
Lact, O-sufo-Lact CMFRP Protein modification 43 
5 
 
O-Cyanate Lact. CMFRP Surface immobilization 
Microarray 
44 
Azide Glc ATRP Protein modification 45 
Biotin GlcNAc ATRP Surace immobilization 46 
Malimide Man ATRP Protein modification 47 
Pyridine 
disulfide 
GlcNAc ATRP Protein modification 48 
Biotin Gal RAFT  49 
Biotin Glc, Lact RAFT and post 
conjugation 
Surface immobilization  50 
Alkyne GalNAc RAFT 
and post conjugation 
Microarray 51 
Biotin GlcNAc, Man RAFT Surface immobilization 52 
Biotin Glc, Gal, 
Man,Fuc,Rham, Xyl, 
Lact,6α-mannobiose 
Panose,                                
GlcNAc, GalNAc,  N-
acetyllactosamine, 
Antigen H, 
SialylLacNAc, Lacto-N-
fucopentanose II, Sialyl 
Lewis X 
RAFT 
and post conjugation 
Microarray 53 
 
     The two significant features of these chain-end functionalized glycopolymer are 
multivalency, which aids for high affinity and specificity for bimolecular recognition and 
6 
 
chain-end functional group that facilitates oriental immobilization of glycopolymer on to 
solid surfaces to mimics cell surface carbohydrates. These glycopolymers were 
covalently attached to, proteins, viruses, nucleic acid, nanoparticles, silica gel beads and 
glass slides by chain-end functional group for protein modification and capturing 
applications (Fig 2). Amongst all applications summarized, capturing of carbohydrate 
binding protein by glycanarray technique is widely used and exhibits high potential for 
development as a high-throughput analytical tool for investigating biological processes 
engaged with carbohydrates. To date, many applications were demonstrated by chain-end 
functionalized glycopolymers with model proteins like lectins to exhibit their potential as 
an analytical tool for studying biological processes. Recent advances in living radical 
polymerization have provided methods to build chain-end functionalized glycopolymers 
with a whole range of biological recognition abilities. 
 
Figure 2. Biomedical applications of chain-end functionalized glycopolymers. 
7 
 
1.3 Glycanarray 
     Microarray techniques have been developed as an analytical tool for studying 
biological processes. DNA microarrays were first to be developed for analyzing mutation 
of genes, studying changes in the gene expression patterns in disease conditions and 
tracking the activities of genes at several times,
54-57
 later protein microarrays have been 
developed as a high-throughput tool to study protein-protein interactions and to study 
protein expressions in normal and diseased states.
58-62
 At first carbohydrate microarrays 
have been developed to study the interactions between carbohydrates and carbohydrate 
binding molecules like proteins,
63-64
 antibodies,
65
 pathogens
66
 etc,. Unlike DNA and 
protein microarray development of carbohydrate microarrays courses more challenges 
like sugars must be displayed at the reducing end for being recognized by the 
carbohydrate binding molecules, the isolation and synthesis of carbohydrates are very 
challenging and moreover the interactions between carbohydrates and proteins is stronger 
and specific when the carbohydrates are present in a multivalent component (cluster 
effect). Initial microarrays were developed with monovalent carbohydrates or the 
oligosaccharides immobilized direly with the help of several linkers or functionalization 
of carbohydrates.
63-66 
Later several multivalent carbohydrate molecules like 
glycodendrimers, glycopolymers, glycoliposomes, neoglycoproteins, glyconanoparticles 
etc were developed to achieve more specific and strong binding of proteins to 
carbohydrate microarrays. It is understood that not only the multivalency of the 
carbohydrates effect the binding specificity also the density and orientation of the 
carbohydrates present on the solid surface effects the interactions significantly i.e. the 
tight binding of proteins to carbohydrates on the array surface depends on multivalency 
8 
 
of carbohydrates with appropriate spacing and orientation of carbohydrates on the 
surface. 
 
1.4 Surface Plasmon Resonance 
     Surface Plasmon resonance (SPR) imaging is a surface sensitive optical technique that 
is used for monitoring label free bio-molecular interactions in liquids.
66-67
 It has several 
applications in the field of life sciences, electrochemistry, chemical vapor detection and 
food and environmental safety. Especially in the field of life sciences SPR is applied to 
determine the bio-molecular interactions and also to determine the association and 
dissociation kinetics between bio-molecules like protein-protein,
68-69
 DNA-protein,
70-72
 
DNA-DNA,
73-74
 antigen-antibody,
75-76
 protein-carbohydrate
77-79
 etc. Surface Plasmon 
Resonance is a phenomenon that occurs when polarized light hits a metal film at the 
interface of media with different refractive indices, in which light is focused onto a metal 
film through a glass prism and the subsequent reflection is detected (Fig 3). Briefly, the 
ligand is immobilized onto a gold chip and the analyte is passed over the ligand with 
continues flow. As the analyte binds the ligand, the addition of mass on the surface 
results in an increase in the refractive index and shift of angle from I to II (Fig 3). This 
change in the refractive index is measured in real time and plotted as response units 
versus time as sensorgram (Fig 3). SPR technique have several advantages like flexible to 
use with several bio-molecules, requires no radioactive or fluorescent labeled samples, 
very minute amount of sample required and also can study the molecular interactions in 
real-time. SPR also have some limitations like nonspecific interactions between sensor 
9 
 
surface and sample, background refractive index variations due to different buffers used 
in running buffer sample, sample temperature etc.
80 
   
 
Figure 3: Surface Plasmon Resonance: Change in the refractive index with addition of 
mass onto the sensor chip, and shift of angle from I to II (lower left) plotted in real time 
as sensorgram (lower right). Cited from Nature Reviews Drug Discovery, 1,515-528 
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CHAPTER II 
 
ORIENTATED GLYCO-MACROLIGAND FORMATION BASED ON 
SITE-SPECIFIC IMMOBILIZATION OF O-CYANATE CHAIN-END 
FUNCTIONALIZED GLYCOPOLYMER 
 
2.1 Introduction 
     Glycopolymers as a multivalent clustering of carbohydrate derivates have proven to be 
an effective tool in the study of carbohydrate-based cellular processes and show great 
potential in biomedical applications like glycomics, biotechnology, biosensors, and 
medicine. For example, glycopolymers have been explored for the development of 
therapeutic agents,
1 
in bio and immunochemical assays,
2
 and as biocapture reagents
3
 
applications. It has been found that the shape and size of glycopolymers
4
 as well as the 
density and relative positioning of their glycan appendages
5
 turned out to be of high 
importance regarding their effectiveness in bio-interactions. Therefore, a large variety of 
various glyco-homo- and (block) copolymers, linear or branched, are reported realizing 
17 
 
high control over the molar mass and the structure of the products.
6
 Furthermore, surface-
bound multivalent glycan ligands were shown to exhibit higher avidity to protein 
receptors compared to immobilized monomeric glycans.
7 
We first reported a biotin chain-
end functionalized glycopolymer for oriented glyco-surface engineering based on specific 
non-covalent interactions.
8-11
 Since then, several groups had demonstrated the potential of 
biotin chain-end functionalized glycopolymers for bioconjugation applications.
12-16
 
 
Chain end functionalized glycopolymers were synthesized by the following techniques. 
 
2.1.1 Synthesis of chain-end functionalized glycopolymer via ROMP 
ROMP using a ruthenium-catalyst was frequently employed to synthesize 
glycopolymers in the early 1990s. ROMP allows glycomonomers to be polymerized in a 
controlled/living fashion, which will then enable the synthesis of block copolymers. The 
catalysts used in ROMP are tolerant to many functional groups, thus permits the synthesis 
with unprotected glycomonomer. In addition, the metal alkylidene catalysts could 
potentially allow the preparation of specifically end-labeled compounds used for 
detection in biological systems. Kiessling and co-workers first employed ROMP 
technique for synthesis of bifunctionalized glycopolymer containing an enol ether at one 
end and a masked carboxylic acid at the other end to which a fluorescein derivative was 
conjugated.
17
 Recently, Linda C. Hsieh-Wilson et al. reported a synthesis of biotin chain-
end functionalized glycopolymers that mimic the native-like, multivalent architecture 
found on chondroitin sulfate (CS) proteoglycans  via ROMP.
18
 Overall, ROMP combined 
with post-polymerization modification method provided the chain-end functionalized 
glycopolymers. Although this method often requires an excess of substrate as well as 
18 
 
some purification, it can still be useful. However, one may also argue that the toxic heavy 
metals used in ROMP could potentially contaminate the final polymers; hence the 
removal of these catalysts has to be scrutinized if the products are to be used in 
biomedical applications.
19
 
 
2.1.2 Synthesis of chain end functionalized glycopolymer via ATRP 
ATRP is a control radical polymerization technique that has been widely 
employed to prepare glycopolymers.
20
 With this technique, glycopolymers of predictable 
molecular weights, narrow molecular weight distribution furthermore wide range of 
functional groups were synthesized. M. G. Finn co workers employed the Cu
I –catalyzed 
ATRP and azide-alkyne cycloaddition reactions together for the synthesis of chain-end 
functionalized glycopolymers and their attachment to a suitably modified viral protein 
scaffold.
21
 Later, Geng et al. synthesized malimide chain-end functionalized 
glycopolymer by combining ATRP and Huisgen [2+3] cycloaddition.
22
 In this study, 
bovine serum albumin (BSA) was employed as a single thiol-containing model protein to 
test the conjugation between thiol and malimide. A fluorescent tag rhodamine B dye was 
introduced into polymer back bone to improve the characterization of polymer protein 
conjugation and also for monitoring of their in vitro studies.  
ATRP technique was also employed by Maynard and coworkers to synthesize a 
biotin chain-end functionalized glycopolymer with N-acetyl-D-glucoamines as pendent 
carbohydrates.
23
 They synthesized both protected and deprotected glycomonomers and 
subjected them to polymerization, interestingly, by both ways well-defined 
glycopolymers with narrow polydispersity were achieved. Also different molecular 
19 
 
weight polymers by altering the initial monomer-to-initiator ratios ([M]o/ [I]o) were 
synthesized and the molecular weights (Mn) and polydispersity were determined by gel 
permeation chromatography. The same group later synthesized a pyridyl disulfide chain-
end functionalized glycopolymer with the same N-acetyl-D-glucoamines as pendent 
carbohydrate.
24
  
Overall, ATRP represents an excellent avenue to controlled polymerization of 
glycomonomers. The advantage of ATRP is the lower polymerization temperature. The 
temperature during polymerization is particularly crucial as glycopolymers and their 
monomers are usually unstable at temperatures higher than 120
o
C.
25
 A concern is the use 
of toxic Cu ions to control the polymerization, which demands the thorough purification 
of the glycopolymer if it is for biomedical application.  
 
2.1.3 Synthesis of chain end functionalized glycopolymer via RAFT 
The RAFT polymerization is carried out with thiocarbonylthio compounds (of the 
general formula Z-C(dS)-SR, known as RAFT agents), which reversibly react with 
growing radicals via chain transfer reactions. Consequently, chains undergo successive 
active/dormant cycles that minimize radical termination processes and lead to a 
simultaneous growth of all chains. The obtained polymer chains are characterized by the 
presence of R and Z groups from the RAFT agents at their α- and ω-ends, respectively. 
Then, the modification of the structure of the RAFT agent, that is, the R and Z groups, 
appears as a highly powerful means for introducing a molecule of interest at polymer 
chain ends. Therefore, RAFT is one of the promising techniques employed for the 
synthesis of glycopolymers with chain-end functional groups. Ravin Narain et al. 
20 
 
synthesized a series of glycopolymers using two different glycomonomers by RAFT 
technique; further these glycopolymers were evaluated for synthesis of 
glyconanoparicles.
26
 Charreyre et al. reported a synthesis of biotin chain-end 
functionalized glycopolymer - poly(NAM-co-GalAm) via RAFT technique using biotin-
CTA.
27
 
Direct polymerization of sugar-containing monomers has been proven to be 
successful; modification of preformed polymers using saccharide-containing reagents 
offers an alternative synthetic route. Betrozzi et al. have synthesized an orthogonally end 
functionalized glycopolymer via RAFT and post-functionalization with saccharides.
28
 
They synthesized mucin mimetic glycopolymer, with one end terminal bearing a surface 
attachment element and the other end set for conjugation of a reporter group.  
Using RAFT technique, the same group later reported a synthesis of biotin-
terminal poly(acryloyl hydrazide) (PAH) scaffold which could be conjugated to a range 
of reducing sugars from simple mono- and disaccharides to highly complex human milk 
and blood oligosaccharides.
29
  
Overall, RAFT polymerization is a popular route for synthesizing glycopolymers. 
Reaction temperatures used in RAFT polymerization are usually between 60 to 70
o
C, but 
also the synthesis of polymers at room temperature is possible. The robustness of this 
polymerization technique is reflected by the number of publications reporting the 
synthesis of glyopolymers in past decade by RAFT technique. Comparing to direct 
polymerization, the post-functionalization approach was demonstrated to be a convenient 
to produce libraries of glycopolymers with the same macromolecular architecture by 
attaching different sugar moieties to pre-formed polymer scaffolds. The drawback of the 
21 
 
post-functionalization is the unsure reaction yield of saccharide modification, which 
might lead to uncontrolled glycopolymers with different saccharide units in the polymer 
and low reproducibility as well. 
 
2.1.4 Synthesis of chain end functionalized glycopolymer via CMFRP 
     CMFRP of unprotected glycomonomers can be conducted in aqueous solution, is 
tolerant of a broad range of functional groups including -OH, -NH2, -COOH, and SO3
-
 
moieties, and can yield glycopolymers with low polydispersity (PDI < 1.5). CMFRP is a 
straightforward approach to synthesize chain-end functionalized glycopolymers using 
functionalized arylamine initiators.  
In this study we designed a facile synthesis of amine and carboxylic acid chain-
end functionalized glycopolymers via cyanoxyl mediated free radical polymerization 
(CMFRP) by using amine and carboxylic acid functionalized aryl amine as initiator, 
respectively.
11 
Interestingly, all these glycopolymers have an O-cyanate group at the other 
chain-end, which might serves as a reactive chain-end group, but not being investigated 
yet. During the past decades, O-cyanate-based isourea bond formation has been proven to 
be a very useful tool in bioconjugate chemistry such as protein and antibody 
immobilization.
30-32 
Therefore, we envisioned that the chain-end O-cyanate group of the 
glycopolymer provides an anchor for site-specific and covalent immobilization of the 
glycopolymer onto an amine surface via isourea bond formation and thereby facilitates an 
oriented glyco-macroligand formation (Fig 1). Herein, we report the oriented glyco-
marcroligand formation and its glyco-affinity capturing and glycoarray application by 
22 
 
combining O-cyanate chain-end functionalized glycopolymer with commercially 
available amine-modified silica gel and glass slide via isourea bond formation, 
respectively. In this study, the multivalent lactose units serve as model affinity 
carbohydrate ligands for lectins
33
 and cells surface carbohydrate such as GM3 for 
carbohydrate-carbohydrate interaction-based cell – cell intereactions.34 
 
Figure 1.  Chemical structure of O-cyanate chain-end functionalized glycopolymer and 
its oriented glyco-macroligand formation via isourea bond formation. 
 
2.2 Experimental 
2.2.1 Materials and methods 
All solvents and reagents were purchased from commercial sources and were used as 
received, unless otherwise noted. Deionized water with a resistivity of 18 Mcm was 
used as a solvent in all polymerization reactions. Glycomonomer, 2-N-Acryoyl-
aminoethoxyl 4-O-(β-D-galatopyranosyl)-β-D-glucopyranoside (3) was synthesized as 
described in reported method.
11
 Thin-layer chromatography (TLC) was performed on 
23 
 
Whatman silica gel aluminum backed plates of 250 µm thickness on which spots were 
visualized with UV light or by charring the plate after dipping in 15% H2SO4 in 
methanol. Dialysis was performed on cellulose membrane with a molecular weight cutoff 
of 3K with water as solvent. 
1
H spectra were recorded at room temperature with a Varian 
INOVA 300 MHz spectrometer. In all cases, the sample concentration was 10 mg/mL, 
and the appropriate deuterated solvent was used as an internal standard. UV-vis 
absorbance spectra were recorded on Varian Bio50 UV-vis spectrometer. IR spectra were 
measured on Broker FT-IR spectrometer. Fluorescence spectra were measured on Hitachi 
F-7000 Fluorescence Spectrophotometer. 
 
2.2.2 Synthesis of O-cyanate chain-end functionalized glycopolymer 4  
In a three-necked flask, dissolved 4-chloroaniline (21.6 mg, 1.69 x 10
-4
 mol), sodium 
nitrite (14.1 mg, 2.04 x 10
-6
 mol) in a mixture of 2 mL water and THF (1:1, v/v). To the 
above mixture, added  HBF4 (66 mg, 7.51 x 10
-4
 mol) and allowed it to react for 30 min at 
0°C under Ar atmosphere. Following this, a degassed mixture of 2-N-Acryoyl-
aminoethoxyl 4-O-(β-D-galatopyranosyl)-β-D-glucopyranoside 3 (186 mg, 2.65 x 10-5 
mol), acryl amide (210 mg, 2.65 x 10
-4 
mol) and NaOCN (55.2 mg, 8.49 x 10
-4
 mol) 
dissolved in 1 mL of water was added into the flask containing diazonium salt. The 
reaction solution was thus heated at 65°C for 16 hrs, and then was filtered to remove any 
precipitates. The resultant mixture is separated of any inorganic salts and impurities by 
dialysis against deionized water for 2 days at room temperature to afford glycopolymer 4 
(248 mg). The conversion yield was about 60%, which was determined by weight for the 
resultant glycopolymer. 
24 
 
2.2.3 Quantification of carbohydrate in glycopolymer (Phenol-Sulfuric Acid Assay)  
Phenol-sulfuric acid assay was used to quantify the lactose molecules attached on the 
glycopolymer 4. To 0.5 mL of sugar solution, added 0.5 mL of 5% aq. phenol solution, 
2.5 mL of H2SO4 (96%) and vortexed the mixture. Prepared the blank with distilled water 
replacing the sugar solution. Allowed above solutions to stand for 30 minutes at room 
temperature and measured the absorbance at 490 nm. A calibration curve of sugar (β-
lactose) concentration versus absorbance (A) was plotted and the presence of sugar on the 
polymer was detected by measuring the absorbance of glycopolymer samples (0.1 moles, 
0.5 moles and 1 mole). 
 
2.2.4 Immobilization of glycopolymer 4 onto amine-modified silica gel through isourea 
bond formation and its affinity lectin capture 
Glycopolymer 4 (8.5 mg, 1.21 x 10
-3 
mol) was added to 200 mg of amine functionalized 
silica gel beads (Sigma) in 2 mL of NaHCO3 buffer (pH 8.3).  The mixture was shaked 
for 4 hrs at room temperature and then was packed into a column. The column was 
washed with NaHCO3 buffer (pH 8.3) followed by PBS buffer (pH 7.4). Lectin-FITC 
solution (Arachis hypogae, FITC-Labeled, 0.5 mg, 4.16 x 10
-9 
mol) in PBS buffer (pH 
7.4) (1 mL) was loaded onto the column. The drained solutions were collected and 
preserved for further analysis. The column was then washed with PBS buffer (pH 7.4) to 
remove the unbounded lectin. Finally, the captured lectin was released by eluting with 
free lactose (1 M) and was analyzed by SDS-PAGE and quantified by fluorescence 
spectroscopy.  
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2.2.5 Oriented glycopolymer glycoarray via O-cyanate-based isourea bond formation 
Glycopolymer microarrays were fabricated by microcontact stamping with MicroCaster 
Arrayer (Whatman). The MicroCaster array tool (spot size 500 µm diameter) was inked 
with a solution of glycopolymer (4, 1 mg/mL, 1.4 x 10
-7
 moles) in NaHCO3 buffer (pH, 
8.3). The MicroCaster tool was pressed onto amine functionalized glass slide (Xenopore, 
Co) for 10 min. The glass slide was incubated in a humidifier chamber for 4 hrs and then 
washed for 1 hr (3 times) with respective buffers followed by washing with PBS 
containing 0.2% tween 20 (PBST) to minimize nonspecific binding of proteins to the 
surface. Then the glass slides were incubated with lectin-FITC (Arachis hypogae, FITC-
Labeled, Sigma) solution (0.2 mg/mL) in PBST (pH 7.4) buffer for 3 hrs followed by 
extensive washing with PBST buffer for 1 hr and subjected to fluorescent imaging by 
using Typhoon 9410 Variable Model Imager (Amersham Biosciences, USA). A control 
was prepared by incubating the glycopolymer printed glass slide with lactose (200 mM, 
PBS (pH 7.4)) pre-incubated lectin-FITC. 
 
2.3 Results and discussion 
2.3.1 One-pot synthesis and characterization of O-cyanate chain-end functionalized 
glycopolymer 
     The synthesis of glycopolymer with chain-end functionalized still poses significant 
challenges, including a requirement for serial protection/deprotection steps or further 
polymer derivatization after initial synthesis. In the present study, the O-cyanate chain-
end functionalized glycopolymers were synthesized via our previously developed 
cyanoxyl free radical mediated copolymerization scheme in one-pot fashion (Scheme 
26 
 
1).
18
 Briefly, 4-chloroanaline 1 was used as initiator for the copolymerization of 
acrylaminoethyl lactoside 3 and acrylamide. Specifically, cyanoxyl radicals were 
generated by an electron-transfer reaction between cyanate anions from a sodium cyanate 
aqueous solution and aryl-diazonium salts prepared in situ through a diazotization 
reaction of arylamine in water. In addition to cyanoxyl persistent radicals, aryl-type 
active radicals were simultaneously produced, and only the latter species was capable of 
initiating chain growth. A series of O-cyanate chain-end functionalized glycopolymers of 
varying sugar density were prepared by altering glycomonomer (GM) and acrylamide 
(AA) in good conversion yield (60-70%) and low polydispersity (1.1 < Mw/Mn < 1.6) as 
described previously.
11
 
 
Scheme 1. Synthesis of O-cyanate chain-end functionalized glycopolymer.  
     The chain-end O-cyanate functional group of glycopolymer 4 was confirmed by IR 
spectrum, in which O-cyanate absorption was observed at 2157 cm
-1
 (Fig 2A). It is also 
noteworthy that the O-cyanate group could be converted to a hydroxyl group by 
treatment with pyridine in water.
35
 Therefore, the disappearing of O-cyanate absorption 
band at 2157 cm
-1
 after pyridine treatment of glycopolymer 4 (to 5) confirmed the 
existing of O-cyanate chain-end group and complete hydrolysis of the O-cyanate group 
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(Fig  2B). By comparison of 
1
H NMR of 4 and 5 (Fig 3), there was no apperent polymer 
structural change observed during the hydrolysis reaction. 
 
Figure 2.  FT-IR spectra of O-cyanate chain terminated glycopolymer 4 (A) and hydroxy 
chain terminated glycopolymer 5 (B). 
1
H NMR spectrum was used to calculate of polymer component content and 
length by using phenyl group at the polymer other chain terminal. As shown in 
1
H NMR 
spectrum of glycopolymer 4 (Fig 3A), comparison of the integrated signal from the 
phenyl protons (7.04 ppm, H2',6' and 7.22 ppm, H3',5') with that due to the anomeric 
protons of lactose (4.36 ppm, H1'-Lact and 4.43 ppm, H1-Lact), as well as that of the polymer 
backbone methine (2.10 ppm, CH) and methylene (1.55 ppm CH2), indicated an average 
glycopolymer composition of 10 lactose and 70 acrylamide units. The molecular weight 
(Mn) was about 7,000 as determined by 
1
H NMR. Furthermore, the grafted carbohydrate 
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on the glycopolymer 4 was quantified via the phenol-sulfuric acid method.
37
 Briefly, 
concentrated H2SO4 was added directly into a solution of phenol and glycopolymer 4. 
The mixture was then vortexed, and allowed to stand for 30 min at room temperature. 
The optical density was then recorded at 490 nm. As a result, there was an average of 8 
lactose units per polymer (Fig 4) , which is close to that determined by the 
1
H NMR 
above. 
 
Figure 3. 
1
H NMR spectra of O-cyanate chain terminated glycopolymer 4 (A) and 
hydroxyl chain terminated glycopolymer 5 (B) in D2O. 
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Figure 4.  a.UV Absorbance spectrum of sugar-phenol conjugate b. A calibration curve 
of sugar (β-lactose) concentration versus absorbance (A) 
 
2.3.2  Immobilization of glycopolymer onto silica gel via O-cyanate-based isourea bond 
formation and its affinity chromatography application  
     Silica gel has been widely used as small, rigid particle for high performance affinity 
chromatography since it is capable of withstanding the high flow rates and /or pressures. 
The introduction of functional groups on a silica surface to yield modified silica gel has 
received great attention for the development of functionalized silica gel for 
chromatography application.
37
 In particular; methods such as covalent grafting of 
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polymers or coating with hydrophilic polymers have succeeded in passivating the silica 
surface and conferring specificity. Recently, silica materials containing covalently bound 
sugars have been explored for boron removal
38
 and isolation and purification of lectins
39-
40 
applications. In the present study, oriented immobilization of multivalent carbohydrates 
onto silica gel surface was investigated for efficient and inexpensive isolation and 
purification of carbohydrate-binding proteins (Fig 5). Briefly, O-cyanate end-terminated 
glycopolymer 4 was immobilized onto the surface of silica gel by incubation of 4 with 3-
aminopropyl-functionalized silica gel (Sigma) in sodium bicarbonate (pH 8.3) buffer 
solution at room temperature for 2 hrs and followed by thoroughly washing with di water 
three times. Control experiment with the hydroxyl chain-end functionalized 
glycopolymer 5 was conducted in the same scale. The amount of glycoplymer 
immobilized on the silica gel was determined by phenol-sulfuric acid method 
37
. Briefly, 
phenol solution was added to a solution of glycopolymer-silica gel, and mixed. Then 
concentrated H2SO4 was added directly into the solution. The mixture was then vortexed, 
and allowed to stand for 30 min at room temperature and finally centrifuged. The optical 
density of the supernatant was then recorded at 490 nm. As a result, there was an average 
of 276 nmol of O-cyanate chain terminated glycoplymer 4 per gram of silica gel, while 
there was no detectable glycopolymer determined with hydroxyl chain terminated 
glycopolymer 5 treated silica gel. This result indicated specific immobilization of 
glycopolymer through isourea bond formation. 
Once the glycopolymer-silica gel (GP-SG) was synthesized, its ability to capture 
lectin was evaluated as an adequate methodology to characterize and determine their 
potential applicability as a chromatographic support. The characterization was carried out 
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by packing the glycopolymer-silica gel in a column followed by saturating the column 
with a β-galactose-specific lectin (Arachis hypogae, FITC-Labeled, 0.5 mg, 4.16 x 10-9 
mol, Sigma) in PBS (pH 7.4) buffer solution and followed by washing with PBS (pH 7.4) 
buffer to remove the unbounded lectin (Fig. 5A). Lectin capturing was confirmed with 
visualization of FITC-labeled lectin on the glycopolymer silica gel column under UV 
lamp (Fig 5B1), while raw silica gel showed little non-specific capturing of the lectin 
(Fig 5B2). Further, there was no capturing was observed for the non-specific lectin 
(glucose/mannose-specific Concavalin A) on the glycopolymer silica gel (data not 
shown). Next, eluting the column with 1 M free lactose in PBS (pH 7.4) buffer released 
the specific captured lectin on the glycopolymer-silica gel (Fig 5C1). A similar protocol 
was followed with raw silica that was thus established as a control assay (Fig 5C2). The 
lectin-capturing capacity was 13.9 nmol of lectin per mg of silica gel modified with 
glycopolymer, while 2.9 nmol of lectin per mg of raw silica gel as non-specific binding 
as determined by fluorescence intensity analysis. Finally, the specific captured lectin was 
confirmed with SDS-PAGE (Fig 6). Specifically, the captured lectin on glycopolymer 
modified silica gel was confirmed on protein staining gel (Gel A, lane 4) and silver 
staining gel (Gel B, lane 4), while no non-specific lectin (glucose/mannose-specific 
Concavalin A) on the glycopolymer silica gel was observed on protein staining gel (Gel 
A, lane 5) and silver staining gel (Gel B, lane 5). These results demonstrated the 
successful oriented glyco-marcroligand formation and its carbohydrate-binding protein 
purification and identification capacity. 
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Figure 5.  Illustration of glycopolymer immobilization onto silica gel and its lectin 
capturing onto glycopolymer-silica gel (A), Lectin capturing onto glycopolymer-silica gel 
column (B1) and raw silica gel (B2), after elution with free lactose (C1 and C2). 
 
 
Figure 6.  SDS-PAGE identification of unbound and released lectins from silica gel 
beads (A: silver staining; B: Protein staining): M: MW marker, 1: lectin alone, 2: 
unbound lectin from glycopolymer-silica gel, 3: unbound lectin from control raw silica 
gel, 4: captured lectin eluted from glycopolymer-silica gel, 5: non-specific lectin eluted 
from glycopolymer-silica gel. 
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2.3.3 Oriented glycopolymer glycoarray via O-cyanate-based isourea bond formation 
     Surface-bound multivalent glycan ligands showed higher avidity to protein receptors 
compared to immobilized monomeric glycans.
14
 Inspired by this example, we sought to 
develop oriented glycopolymer array that spatially position the pendant glycans similarly 
to natural glycoproteins. Specifically, integration of such constructs into arrays may 
create a more physiologically authentic platform for probing glycan binding proteins. In 
the present study, glycopolymer microarray (spot size 500 µm diameter) was fabricated 
by microcontact stamping glycopolymer 4 onto amine functionalized glass slide 
(Xenopore, Co) in NaHCO3 buffer (pH, 8.3) (Fig 7). The glass slide was incubated in a 
humidifier chamber for 4 hrs and then washed for 1 hr (3 times) with respective buffers 
followed by washing with PBS containing 0.2% tween 20 (PBST) to minimize 
nonspecific binding of proteins onto the surface. Then the glass slides were incubated 
with lectin-FITC (Arachis hypogae, FITC-Labeled, Sigma) solution in PBST buffer for 3 
hrs followed by extensive washing with PBST buffer for 1 hr and finally subjected to 
fluorescent imaging. A control was prepared by incubating the glycopolymer arrayed 
glass slide with lactose (200 mM) pre-incubated lectin-FITC instead of free lectin. 
Fluorescence microscopy analysis of the surfaces revealed specific binding of lectin only 
to the immobilized glycopolymer (Fig 7B). The lectin binding to arrayed glycopolymer 
was inhibited in the presence of free lactose (Fig 7C), further confirming the specific 
lectin binding to the glycopolymer. Moreover, glycopolymer array with different 
concentration of glycopolymer showed concentration-dependent lectin binding to 
glycopolymer (Fig 7D).  These observations indicated that arrayed glycopolymers can 
distinguish glycan-binding proteins based on their ligand specificity. 
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Figure 7.  Glycopolymer microarray for probing specific glycan–protein interactions (A),  
fluorescent imaging of FITC-labeled lectin binding to microarrayed patterns of 
glycopolymers  (B), control with lactose pre-incubated lectin-FITC (C) and with different 
concentration of glycopolymer in array (a: 0.001 mg/mL, b: 0.1 mg/mL and c: 0.5 
mg/mL) (D). Bar size: 500µm. 
 
2.4 Conclusions 
     An oriented glyco-marcroligand formation based on O-cyanate chain-end 
functionalized glycopolymer with commercially available amine modified silica gel and 
glass slide via isourea bond formation was demonstrated, respectively. The O-cyanate 
chain-end functionalized glycopolymer was synthesized via one-pot cyanoxyl mediated 
free radical polymerization. It is notable that the polymerization can be performed under 
aqueous condition and is tolerant of a wide range of monomer functionalities, including -
OH, -COOH, -NH2 and -OSO3
-
 groups.
18
 Therefore, there is no protection and 
deprotection needed and thus is a straightforward approach.  
Notably, multivalent lactose units serve as model ligands but can be changed to any 
specific carbohydrates for specific lectins or cells. The chain-end O-cyanate group of the 
polymer provides an anchor for site-specific and covalent immobilization of the 
B C D 
a   b   c 
A 
Lectin Glycopolymer 
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glycopolymer onto any amine surface via isourea bond formation in mild condition, 
which can be used for biosensor and glycoarray applications. In addition, the chain-end 
functionalizable glycopolymer can be used for polymer-protein conjugation as well.  
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CHAPTER III 
 
GLYCO-MACROLIGAND MICROARRAY WITH CONTROLLED 
ORIENTATION AND GLYCAN DENSITY 
 
3.1 Introduction 
     Glycan microarray has become powerful high-throughput tool for examining binding 
interactions of carbohydrates with lectins, antibodies, cells, and viruses.
1
 Recently, it has 
been applied to clinical antibody detection and profiling,
2
 vaccine development,
3
 
biomarker discovery,
4
 and drug screening
5
 applications. Nevertheless, they are still not 
perfect for clinical applications and novel microarray designs are much needed to 
improve the performance of this technology. Two critical limitations prevent wide and 
potential applications of the glycan microarray technology. First, the detection is limited 
by restricted epitopes available for microarray fabrication from both synthesis and 
isolation from nature sources. Second, the features of glycan presentation on the 
microarray surface such as density and orientation of glycans have substantial effect on 
protein recognition related to both affinity and specificity. Conventional glycan 
microarrays were made by directly immobilizing glycans onto microarray surfaces by 
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either physical absorption or covalent conjugation, which directly mimics the multivalent 
display of carbohydrate epitopes on the cell surface. However, this two dimensional (2D) 
surface immobilization chemistry usually results in low signal intensity and substantial 
non-specific binding of target proteins due to an insufficient number of accessible 
glycans and the presence of surface-protein interactions. To overcome this limitation, 
recently, glycan density on the array surface has been recognized as very important 
feature of carbohydrate recognition and thus has been investigated extensively.
6-12
 
A general strategy for modulating glycan density is to vary the concentration of 
the monovalent glycans in the printing solution that is being spotted onto a microarray 
slide. However, this approach is not generating variations in density in the molecular 
level and often yields inconsistent results. Particularly, often variations in density 
gradient over the spot are seen when the surface is not saturated with diluted printing 
solution. Alternatively, new strategies have been developed, in which multivalent 
glycoconjugates with varying density were first synthesized, and then printed onto a solid 
support to generate a microarray of multivalent glycans in different densities.  
Another key feature of the glycan presentation in glycan microarray is the glycan 
orientation. Cell surface glycans are spatially displayed such as glycoprotein scaffolds 
with three-dimensional (3D) geometries. However, conventional glycan arrays present 
glycans on a 2D substrate and thus have limited activity. Early study confirmed that 
surface-bound multivalent glycan ligands show higher avidity to protein receptors 
compared to immobilized monomeric glycans.
13
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3.1.1 Glycodendrimer-Based Glycoarray 
     Pieters and coworkers have studied the binging of lectins to carbohydrates with 
respect to the effect of multivalency of carbohydrate moieties and the inter-binding-site 
distances of lectins
14-15 
They primarily started with synthesized mannose based 
glycodendrimers and tested against two different lectins ConA and WGA
14
 later enlarged 
their work by synthesizing five different glycodendrimers to evaluate a series of lectins.
15
 
The same phenomenon was observed with the other eight lectins that were tested against 
five different glycodendrimers, lectins with increase in inter–binding-site distance 
displayed decrease in the multivalency effect.  
Wang and coworkers employed a different approach for construction of 
glycodendrimer microarray in their recent studies
16 
by initially preparing a three 
dimensional dendrimeric platform followed by linking the carbohydrate to the dendrimers 
surface. The cluster effect was tested by spotting oligosaccharides dendrimers of all five 
generation which were further incubated with lectin and observed that with increase in 
the surface groups the fluorescent intensity also increase exhibiting the multivalency 
effect.  
Overall, glycodendrimers were successfully synthesized for microarray applications 
and were qualified in the screening of carbohydrate-protein interactions through 
carbohydrate microarrays. 
These glycodendrimers microarrays not only explored the protein-carbohydrate 
interactions but also reported how the multivalent carbohydrate display on the array 
surface aids the protein binding to carbohydrates in the aspects of both sensitivity and 
selectivity. From the reported glycodendrimers microarrays it is accepted that the 
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multivalency of the carbohydrates is well controllable by dendrimers but the spacing and 
orientation of the carbohydrates on the array surface are not yet organized to study their 
effect on protein binding to carbohydrates. 
 
3.1.2 Neo-Glycoprotein-Based Glycoarray 
     Gildersleeve et al have developed a method for varying both the structure and density 
of the carbohydrates on the carbohydrate antigen microarray and evaluated the density 
dependent binding effects for tumor- binding lectins, monoclonal antibodies and serum 
antibodies.
5
 For this approach they have conjugated carbohydrate to carrier protein like 
bovine serum albumin (BSA), in which the carrier protein served as both the multivalent 
scafold and the linker for immobilization on to glass slides. Carbohydrates were 
conjugated to free amine groups of BSA via reductive amination of oligosaccharides or 
by coupling the oligosaccharides with carboxylic acid via activation with EDC/NHS. To 
vary the density number of carbohydrates attached to the BSA were controlled.  
Gildersleeve’s group17 synthesized several neo-glycoconjugated with variying 
carbohydrate density. They have observed that selectivity of lectins for particular 
carbohydrate over other carbohydrates declined at high density. Followed by this they 
evaluated the density –dependent binding properties of a set of monoclonal antibodies 
and determined that antibodies to the same carbohydrate antigen can recognize density in 
significantly different ways. Also they have tested the density-dependent binding 
properties of serum antibodies of 30 subjects, the results demonstrated that modulation of 
antigen density can be used to reveal differences in antibody populations between 
different subjects. Their results from the above study reveled that both structure and the 
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density of the carbohydrates significantly affect the affinity and selectivity to 
carbohydrate binding compounds.  Gildersleeves et al proved that the density of the 
carbohydrates on the surface are significant in studying in carbohydrate binding ligands. 
 
3.1.3 Liposome-based glycoarray 
     Our group recently investigated the application of azide-reactive liposome for efficient 
and chemically selective immobilization and microarray fabrication
18
. Azide reactive 
liposomes were synthesized with DSPE-PEG2000-triphenylphosphine, phospholipids 
(DSPE) and cholesterol rapid extrusion method. Azide reactive liposomes were 
immobilized on azide functionalized glass slides and later subjected to and lectin binding 
studies were conducted by incubating the liposome immobilized glass slide with lectin 
PNA and observed the lectin binding to lactosylated liposome and no binding observed to 
liposome with just anchor group.  
Later this work was extended to study the glycolipid and protein interactions
19
 by 
incorporating natural and synthetic glycolipids into liposomes, and immobilizing them 
onto an azide functionalized glass slide to test the binding affinities of lectins. These 
microarrays mimic the presentation of carbohydrates on the cell surface and the binding 
curves indicate that the liposomal microarrays with different glycolipids show specific 
density dependent binding capacity and affinity as well.  
 
3.1.4 Glycopolymer-Based Glycoarray 
     Glycopolymers carrying pendant sugar moieties are either synthesized by direct 
polymerization of carbohydrate-containing monomers with protection group or without 
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protection group, or by the post polymerization glyco-conjugation of synthetic 
polymers.
20
 In recent years glycopolymers have been synthesized by several techniques 
for various biomedical applications particularly glycopolymers with end functional group 
have been synthesized excessively for microarray applications. Chain-end functionalized 
glycopolymers demonstrated homogeneous immobilization of the glycopolymer via a 
single terminal anchor to yield an oriented and density controlled displaying of 
multivalent pendent carbohydrates. 
Bertozzi’s group synthesized a duel end functionalized mucin like glycopolymer21 
with a center mucin mimetic domain with N-actylgalactosemamine moieties, one 
terminal alkyne group as surface attachement element and a second terminal outfitted for 
conjugation of texas red as a fluorophore. By microcontact printing the alkyne terminal 
glycopolymers were immobilized onto azide functionalized surface in presence of a 
copper catalyst, which forms a stable triazol linkage to covalently immobilize the 
glycopolymer. As the glycopolymer was also functionalized with fluorescent tag Texas 
red on the other end the immobilization of polymer was confirmed by fluorescent 
microscopy. Also the ligand specificity of glycans of the polymer was tested by 
immobilizing non-fluorescent tag glycopolymer and testing the binding of Texas Red 
tagged Helixpomatia agglutinin (Texas Red-HPA) that recognizes α-GalNAc, the 
analysis of the surface by fluorescent microscopy revealed the specific binding of HPA 
only to α-GalNAc confirming the specific binding of glycans. The same group later, 
developed an approach synthesis of glycopolymers for microarray applications via 
ligation of reducing sugars to backbones carrying hydrazide groups and end functional 
group.
22
 They arrayed a group of biotinylated glycopolymers onto streptavidin-coated 
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glass slides which were recognized by lectins specifically depending on their pendant 
glycans. 
Recently, Linda C. Hsieh-Wilson et al. synthesized a biotin end functionalized 
glycopolymer that mimic chondroitin sulfate proteoglycans via ring-opening metathesis 
polymerization technique
23
 which were employed for microarray and SPR applications. 
Both sulfated CS-E and nonsulfated CS-C glycopolymers were immobilized onto 
streptavidin coated glass slides by high-precision contact-printing robot which delivers a 
nanoliter volmes  of glycopolymer onto glass slides. Polymer immobilized glassslides 
were tested for binding of specific monoclonal antibodies  2D11 and 2D5, which are 
selective for CS-E and CS-C glycopolymers respectively. And they also studied the 
binding of a growth factor, glial cell-derived neurotropic factors selective for sulfated 
epitopes, which showed higher selectivity for CS-E compared to CS-C by both 
microarray and SPR techniques. 
Nevertheless, the density of the immobilized glycopolymer on the array surface is 
still uncontrollable, and thus, the possibility to access the multivalent glycans in parallel 
might be limited and thus does not facilitate maximum protein binding affinity and 
specificity. In this study, we studied an oriented and density controlled glycopolymer 
microarray formation based on end-point immobilization of glycopolymer combined with 
molecular spacing technique. Briefly, O-cyanate chain-end functionalized glycopolymer 
was pre-complexed with boronic acid ligands in different sizes and then immobilized 
onto amine-functionalized glass slide via isourea bond formation at high pH value (pH 
10.3 buffer). Once the immobilization is complete, the spacer boronic acid ligands were 
released from the immobilized glycopolymers at a reduced pH value (pH 7.4 buffer) 
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condition so as to afford the oriented and density controlled glycopolymer microarray 
(Fig 1). This glyco-macroligand microarray platform will facilitate both affinity and 
specificity of protein binding and thus will provide a versatile tool for profiling glycan 
recognition for both basic biological research and practical applications.  
 
 
Figure 1. Schematic illustration of orientation and density controlled glycopolymer 
microarray formations based on end-point immobilization of glycopolymers that were 
acompanied with boronic acid (BA) ligands in different sizes as temporory molecular 
spacers followed by releasing the BA ligands from the immobilized glycopolymers. 
Reaction conditions: i. R1-BA, NaHCO3 buffer (pH 10.3), ii. R2-BA, NaHCO3 buffer (pH 
10.3), iii. R3-BA, NaHCO3 buffer (pH 10.3), iv. NaHCO3 buffer (pH 10.3), v. 1 mM 
Glucose, PBS buffer (pH 7.4) 
 
3.2 Experimental 
3.2.1 Materials and Methods  
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All solvents and reagents were purchased from commercial sources and were used as 
received, unless otherwise noted. Lysozyme, bovine serum albumin, amino phenyl 
boronic acid, FITC-PNA (Arachis hypogae) and alizarin red S were purchased from 
Sigma.  lectin FITC-RCAI (Ricinus communis) was purchased from EY Laboratories. 
amine functionalized glass slides were purchased from Xenopore, Co. 
 
3.2.2 Syntheses of O-cyanate chain-end functionalized glycopolymers 
  Glycopolymers were synthesized according to our previously reported method.
24 
Briefly, in a three-necked flask, dissolved 4-chloroaniline (21.6 mg, 1.69 x 10
-4
 mol), 
sodium nitrite (14.1 mg, 2.04 x 10
-6
 mol) in a mixture of 2 mL water and THF (1:1, v/v). 
To the above mixture, added  HBF4 (66 mg, 7.51 x 10
-4
 mol) and allowed it to react for 
30 min at 0°C under Ar atmosphere. Following this, a degassed mixture of 2-N-Acryoyl-
aminoethoxyl 4-O-(β-D-galatopyranosyl)-β-D-glucopyranoside  (186 mg, 2.65 x 10-5 
mol), acryl amide (210 mg, 2.65 x 10
-4 
mol) and NaOCN (55.2 mg, 8.49 x 10
-4
 mol) 
dissolved in 1 mL of water was added into the flask containing diazonium salt. The 
reaction solution was thus heated at 65°C for 16 hrs, and then was filtered to remove any 
precipitates. The resultant mixture is separated of any inorganic salts and impurities by 
dialysis against deionized water for 2 days at room temperature to afford glycopolymer 
(248 mg). The conversion yield was about 60%, which was determined by weight for the 
resultant glycopolymer. Four kinds of glycopolymers with different ratios of pendant 
glycan and molecular weights (1a, 1b, 1c and 1d) were obtained by using different ratios 
of glycomonomer (GM) to acryl amide (AA) and  were characterized by 
1
H NMR spectra 
(Table 1 and Figure 2).  
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3.2.3 Syntheses of boronic acid (BA) ligands 
3.2.3.1 Synthesis of Lysozyme-BA: To 5 mL ice cold 0.05 M MES (pH 6), add 100 mg of 
lysozyme (6.9 µmoles), 20 mg of aminophenyl boronic acid (APBA) (130 µmoles) and 
10 mg of EDC with constant stirring. The reaction was allowed to take place for 2 hrs at 
room temperature, then adjust the pH to 7 and let the reaction continue overnight at room 
temperature. Separate the salts and the unreacted APBA by centrifugation in 10 kDa cut-
off filter tube for 30 mins. The resultant lysozyme-BA conjugate was characterized by 
SDS-PAGE and Alizarin Red S assay (ARS) assay (Fig. 5A).  
3.2.3.2 Synthesis of BSA-BA: To 5 mL ice cold 0.05 M MES (pH 6), add 100 mg of 
BSA (1.5 µmoles), 20 mg of APBA (130 µmoles) and 10 mg of EDC with constant 
stirring. After 2 hrs, adjust the pH to 7 and let the reaction sit overnight at room 
temperature. Separate the salts and the unreacted APBA by centrifugation in 10 kDa 
cutoff filter tube for 30 mins. The resultant BSA-BA (BSA-BA) conjugate was 
characterized by SDS-PAGE and ARS assay (Figgure 5B).  
 
3.2.4 Glycopolymer microarray formation and lectin binding assay 
MicroCaster microarray tool (Whatman, spot size 500 µm diameter) was inked with a 
solution of glycopolymer (1a, 4.8 X 10
-5
 mM) in NaHCO3 buffer (pH 10.3), then was 
pressed onto an amine functionalized glass slide (Xenopore, Co) at room temperature for 
10 mins. The glass slide was then incubated in a humidifier chamber at room temperature 
for 4 hrs and then washed with NaHCO3 buffer (pH 10.3) for 30 mins (3 times) to 
removed un-reacted glycopolymer, then followed by washing with 0.2% PBST for 30 
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min. The glass slides were then incubated with lectin-FITC (Arachis hypogae), FITC-
Labeled, Sigma, 0.2 mg, 1.61 X 10
-9
 moles) PBS containing 0.2% Tween 20 (PBST) 
solution at room temperature for 3 hrs followed by extensive washing with PBST buffer 
for 30 mins. Finally, the glass slide was subjected to fluorescence imaging and the 
fluorescence intensity was recorded by using Typhoon 9410 Variable Model Imager 
(Amersham Biosciences, USA). In the same condition, glycopolymer microarrays with 
glycopolymer 1b, 1c, 1d were conducted, respectively. 
 
3.2.5 Density controlled glycopolymer microarray formation and lectin binding assays 
 Glycopolymer (1b, 3 mg, 7.7 x 10
-5
 mmoles) was mixed with polyacrylamide-BA ligand 
(3 mg, 1.5 x 10
-4
 mmoles) in 3 mL of 10.3 pH NaHCO3 buffer and was stirred at room 
temperature for 4 hrs. MicroCaster microarray tool (Whatman, spot size 500 µm 
diameter) was inked with the glycopolymer- boronic acidcomplex solution (1 mg/mL, 1:2 
mol) and then was printed onto an amine functionalized glass slide in NaHCO3 buffer 
(pH 10.3). The glass slide was then incubated in a humidifier chamber for 4 hrs and then 
washed with NaHCO3 buffer (pH 10.3) 30 mins (3 times) to remove un-reacted 
glycopolymer and boronic acid ligands. Detachment of boronic acid ligand from the 
immobilized glycopolymer was performed by incubating the glass slide with 7.4 pH PBS 
buffer for 30 mins and followed by 7.4 pH PBS buffer with 1 mM glucose for 10 mins. 
Boronic acid ligands detached from the glycopolymer were confirmed by ARS assay (fig 
7). The glass slide was washed with PBST buffer for 30 mins then incubated with lectin-
FITC (Arachis hypogae, FITC-Labeled, Sigma, 0.2 mg, 1.61 X 10
-9
 moles) in 0.2% 
PBST solution at room temperature for 3 hrs, followed by extensive washing with PBST 
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buffer for 30 mins and subjected to fluorescent imaging and the fluorescence intensity 
was recorded as above. In the same condition, density controlled glycopolymer 
microarray formation of glycopolymer 1b spaced with polyacrylamide-BA in different 
ratios (as shown in Figure 8) were prepared and their lectin binding were tested, 
respectively.  
Similar protocol was followed for glycopolymer 1b microarray formation spaced 
with other two boronic acid ligands conjugates (BSA-BA and Lyz-BA) in different ratios 
(Figure 8)  and their lectin (Arachis hypogae) binding assays, respectively. 
Similar protocol was followed for spaced glycopolymer 1b microarray formation 
spaced with these three boronic acid ligands in different ratios and their lectin Ricinus 
communis (RCAI, FITC-labeled, EY Laboratories, Inc) binding assays, respectively 
(Figure 10).  
 
3.2.6 Control experiments for spaced glycopolymer microarray formation  
Glycopolymer (1b, 3 mg) was mixed with unmodified lysozyme (3 mg) in 3 mL of 10.3 
pH NaHCO3 buffer and was stirred at room temperature for 4 hrs. MicroCaster array tool 
(Whatman, spot size 500 µm diameter) was inked with the glycopolymer/BSA solution (1 
mg/mL) and then was printed onto amine functionalized glass slide in NaHCO3 buffer 
(pH 10.3). The glass slide was then incubated in a humidifier chamber for 4 hrs and then 
washed for with NaHCO3 buffer (pH 10.3) 30 mins (3 times) The glass slide was then 
incubated with lectin-FITC (Arachis hypogae, FITC-Labeled, Sigma, 0.2 mg, 1.61 x 10
-9
 
moles) in 0.2% PBST solution at room temperature for 3 hrs followed by extensive 
washing with PBST buffer for 30 mins and subjected to fluorescent imaging and the 
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fluorescence intensity was recorded as above. Same protocols were followed for 
glycopolymer treated with unmodified BSA, respectively (Figure 9). 
Same protocols were followed for printing glycopolymer with hydroxyl chain end 
group and its complex with polyacrylamide-BA, respectively. 
 
3.2.7 Surface Plasma Resonance (SPR) assay for immobilized glycopolymers spaced 
with boronic acid ligands 
3.2.7.1 Glycopolymer immobilization onto SPR chip:  A CM5 chip (GE health science) 
surface was activated with EDC/NHS 1:1 for 6 mins at 10 µL/min, treated with 70 µL of 
0.1 M ethylenediamine in 8.5 pH 0.1 M borate buffer at 10 µL/min, followed by 70 µL of 
1 M ethanolamine 8.5 pH 0.1 M borate buffer for 7 min at 10 µL/min. Once the amine 
modified surface was generated, glycopolymer (1b) was immobilized by flowing 
glycopolymer solution in 10.3 pH NaHCO3 buffer (0.5 mg/mL) for 7 min at 10 µL/min 
followed by washing with 10.3 pH NaHCO3 buffer for 5 min (flow cell 2). 
Immobilization of glycopolymer was confirmed by observing the increase in response 
from the base line.  
3.2.7.2 Boronic acid ligands spaced glycopolymer immobilization onto SPR chip: CM5 
chip (GE health science) was modified as mentioned earlier to create amine 
functionalization. Glycopolymer pre-modified with polyacrylamide-BA (0.5 mg/mL, 1:2 
mol) in pH 10.3 NaHCO3 buffer was flowed for 7 min at 10 µL/min. Immobilization of 
polyacrylamide-BA modified glycopolymer was confirmed by the increase in response 
from the base line, followed by washing with 10.3 pH NaHCO3 buffer for 5 mins. 
Polyacrylamide-BA was released from the immobilized glycopolymer by flowing with 
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7.4 pH PBS buffer for 7 min. Same procedure was followed to immobilize lysozyme-BA 
pre modified glycopolymer (1b). 
3.2.7.3 Lectin binding onto immobilized glycopolymer: The binding of lectin to 
immobilized glycopolymer was studied by flowing lectin (Arachis hypogae, Sigma). 
Different concentrations of lectin ranging from 0.125 nmoles to 2 nmoles in 7.4 pH PBST 
buffer were flowed through immobilized glycopolymer for 2 mins at 10 µL/min; and the 
amplification of response with respect to increase in lectin concentration was illustrated. 
 
3.3 Results and Discussion 
3.3.1 Glycopolymer microarray formation and lectin binding assay 
     In our previous study, we have demonstrated that O-cyanate chain-end functionalized 
glycopolymer could be immobilized onto amine-functionalized silica gel and glass slide 
surfaces via isourea bond formation.
24
 To fully exploit the potential of the oriented 
immobilized glycopolymer, herein, we examined molecular control of both the density of 
glycan in the glycopolymer and the glycopolymer itself on the microarray surface. First, 
we examined the glycan density effect for lectin binding in the glycopolymer by 
synthesizing a series of glycopolymers with different ratios of pendant glycan and 
molecular weights. Four glycopolymers were synthesized by our previously reported 
method (Fig 2, Table 1).
24
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Figure 2  
1
H NMR spectrum of glycopolymer 1a in D2O, 1b in D2O, 1c in D2O,1d in 
D2O 
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Table 1. O-cyanate chain-end functionalized glycopolymers of different densities 
Glycopolymer GM/AA
a
 GM/AA
b
 Mn(g/mol)
c
 
1a 1/1 (1/18)12 20,700 
1b 1/10 (1/30)12 38,800 
1c 1/20 (1/54)4 17,200 
1d 1/50 (1/51)4 16,300 
 
a. Ratio of GM and AA added. b. Ratio of GM and AA determined by 
1
H NMR. c. 
Molecular weight determined by 
1
H NMR analysis (D2O). 
 
Then, glycopolymer microarrays (spot size about 500 µm diameter) were 
fabricated by microcontact stamping (MicroCaster) of glycopolymers onto amine 
functionalized glass slides (Xenopore Co.) in NaHCO3 buffer (pH 10.3). The glass slides 
were incubated in a humidifier chamber for 4 hrs and then washed for 30 mins (3 times) 
with respective buffers followed by washing with PBST to minimize the nonspecific 
binding of proteins onto the surface. Then, the glass slides were incubated with lectin-
FITC (Arachis hypogae, FITC-labeled, Sigma) solution in PBST buffer for 3 hrs, 
followed by extensive washing with PBST buffer for 30 mins, and are finally subject to 
fluorescence imaging. As shown in Fig 3, glycopolymer (1b) with 1 to 30 ratio of 
lactoseand acryl amide (LT/AA) showed the highest level of lectin binding (Fig 3B) 
compared to the glycopolymers with 1 to 18 (1a) (Fig 3A), 1 to 54 (1c) (Fig 3C)  and 1 to 
51 (1d) (Fig 3D)  ratio of lactose and acryl amide. These results indicated that the glycan 
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density in the polymer has impact for the lectin binding. We chose glycopolymer 1b for 
our continued density controlled glycopolymer microarray study below. 
 
Figure 3. Fluorescence images of glycopolymer microarrays with different glycan 
density after incubation with lectin (Arachis hypogae, FITC-labeled, Sigma). A: 
glycopolymer 1a (LT/AA, 1:18), B: glycopolymer 1b (LT/AA, 1:30), C: glycopolymer 
1c (LT/AA, 1:54), D: glycopolymer 1d (LT/AA, 1:51). LT: Lactose, AA: Acrylamide. 
Bar size: 500 µm. 
 
3.3.2  Syntheses and charecterization of boronic acid (BA) ligands 
     Three macro-boronic acid ligands (2), lysozyme-BA (2a, Mw: about 15 kDa), BSA-
BA (2b, Mw: about 70 kDa) and polyacrylamide-BA (2c, Mw: about 10 kDa) conjugates 
were designed and synthesized as spacing molecules to vary the immobilized 
glycopolymer density since they have different molecular sizes and BA conjugation 
density on it can be variable. Lysozyme-BA 2a and BSA-BA 2b conjugates were 
synthesized by amidation of carboxylic acid groups in lysozyme and BSA with 
aminophenyl boronic acid in the presence of EDC, respectively. Polyacrylamide-BA 
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conjugate 2c was prepared as per our previously reported method.
25
 Lysozyme-BA and 
BSA-BA conjugates were characterized by SDS-PAGE. As shown in Figure 4, the 
comassie staining clearly showed large molecular weight shifts for the protein-BA 
conjugates compared to unmodified BSA and lysozyme (Fig 4A).  Interestingly, the gel 
stained with Alizarin Red S. (ARS) in PBS buffer (pH 7.4) showed similar molecular 
weight shifts for the conjugates but the color of the bands is brown comparing to yellow 
band of the unmodified lysozyme and BSA. The ability of the boronic acid ligands to 
specifically bind with carbohydrate was characterized by ARS-binding assay.
26
 
Qualitative determination of boronic acid conjugation to both BSA and Lysozyme were 
performed by Alizarin Red S assay. Briefly, Alizarin Red S (ARS) exhibits change in 
fluorescence intensity and color by the addition of boronic acid. As shown in Figure 5, 
ARS (a) showed a color change from pink to yellow when bound to boronic acid (b) and 
also a shift in wavelength from 510 nm to 460 nm by UV absorption in PBS (pH 7.4) 
buffer; and by adding free galactose, galactose -boronic acid complex was formed to 
release ARS indicated by a color change from yellow to pink (c) with a shift in 
wavelength to 510 nm from 460 nm. The same pattern of fluorescence intensity and color 
change was observed by both BSA-BA and Lysozyme-BA conjugates as shown in Figure 
5A: ARS plus Lyz (d) no color change, ARS plus Lyz-BA (e) color change from pink to 
yellow and ARS-Lyz-BA plus galactose (f) color change back to pink,  Figure 5B: ARS 
plus BSA (g) no color change, ARS plus BSA-BA (h) color change from pink to yellow 
and ARS-BSA-BA plus galactose (i) color change back to pink. (Fig 5). 
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Figure 4. SDS-PAGE characterization of BSA-BA and lysozyme-BA conjugates: A. 
stained with coomassie blue, B. stained with ARS in PBS buffer (pH 7.4) for 30 mins. 
 
Figure 5. ARS assay of Lysozyme-BA (A) and BSA-BA (B) monitored by UV-Vis 
Spectroscopy 
Also quantitative determination of boronic acid in BSA-BA and Lysozyme-BA 
conjugates was performed by monitoring ARS assay through fluorescence spectroscopy. 
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Solutions of BSA-BA and Lysozyme-BA were added to 1 mM ARS solution in PBS (pH 
7.4) buffer and fluorescence intensity was recorded at 378 nm. From the calibration curve 
made with standard ARS and APBA below (Fig 6), the ratio of BA and protein obtained 
was determined as shown in Table 2. 
 
Figure 6. Calibration Curve of boronic acid by ARS assay monitored by Fluorescence 
Spectroscopy 
 
Table 2. Quantification of BSA-BA and Lyz-BA conjugates from ARS assay by 
fluorescence spectroscopy  
Protein-BA
 
Protein/APBA
a
 (mole) Protein/BA
b
(mole) 
Lyz-BA 1/33 1/4 
BSA-BA 1/87 1/54 
 
a. Ratio of protein and APBA added. b. Ratio of BA and protein determined from 
ARS assay. 
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3.3.3 Density controlled glycopolymer microarray formation and lectin binding assays  
     Molecular imprinting technique has been recognized as a powerful tool for the 
preparation of synthetic polymers with molecular sized cavities that are capable of 
molecular recognition.
27-28
 This technique has been used for chromatographic 
separations,
29
 solid phase extraction,
30
 binding assay
31
 and sensors,
32-33
 and drug 
delivery
34
 applications. Boronic acid-carbohydrate complex formation is a pH-dependent 
reversible process and has been used for the preparation of molecularly imprinted 
polymers targeting sugars.
35-38
 In the present study, we envisioned that the reversible 
interaction between boronic acid and carbohydrate can be used to modulate the density of 
immobilized glycopolymer on the microarray surface by using boronic acid ligands in 
different sizes as “temporary spacing molecules”. Briefly, the glycopolymer was pre-
complexed with boronic acid liands. These assemblies were then printed onto the 
microarray surface, in which the boronic acid ligands temporarily occupy space between 
the immobilized glycopolymers. Once the immobilization was complete, the spacer 
boronic acid ligands are removed leaving empty space behind and thus afforded density 
controlled glycopolymer microarray. The key factor for this innovative fabrication of 
density controlled glycopolymer microarray is the compatible conditions, first the basic 
condition for both boronic acid and carbohydrate complex formation and O-cyanate-
based isourea bond formation immobilization; second, neutral condition for removal of 
spacer boronic acid ligands from the microarray surface (Fig 1). 
The O-cyanate chain end functionalized lactose-containing glycopolymer 1b, 
which showed the highest lectin binding above, was used as a model glyco-macroligand 
for oriented and density controlled glycopolymer microarray formation.  
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The general process for oriented and density controlled glycopolymer microarray 
formation includes three steps as shown in Fig 1. First, prior immobilization, the 
complexes formation between glycopolymer (1b) and spacing broronic acid ligands (2) 
were conducted by mixing 1b and 2 in NaHCO3 buffer (pH, 10.3) for 4 hrs at room 
temperature. Next, MicroCaster array tool (Whatman, spot size 500 µm diameter) was 
inked with the solution of glycopolymer-boronic acid ligand complex in NaHCO3 buffer 
(pH, 10.3), then was pressed onto an amine functionalized glass slide (Xenopore, Co) for 
10 mins at room temperature. The glass slide was then incubated in a humidifier chamber 
for 4 hrs at room temperature. Finally, the spacing boronic acid ligands were detached 
from the immobilized glycopolymer by incubating the glass slides in PBS buffer (pH 7.4) 
solution in the presence of high concentration glucose (1 mM) as well, and followed by 
washing with PBS buffer (pH 7.4) for 30 mins (3 times) so as to afford the expected 
oriented and density controlled glycopolymer microarrays. ARS assay was also used to 
confirm the boronic acid ligands detached from the immobilized glycopolymer, in which 
PBS buffer solution containing ARS turned to brown color from red color upon falling in 
of detached boronic acid ligands from the immobilized glycopolymers on the microarray 
surface (Fig 7).  
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Figure 7. UV spectra of ARS and ARS upon boronic acid ligand detached from the glass 
slide in PBS buffer (pH7.4). BP: polyacrylamide-boronic acid 
For protein binding, the resultant glycoarray glass slides were washed with PBS 
containing 0.2% tween 20 (PBST) first to minimize nonspecific protein binding, then 
incubated with β-galactose specific lectin (Arachis hypogae (PNA) FITC- Labeled, 
Sigma) solution in PBST buffer (pH 7.4, 0.2 mg/mL) for 3 hrs at room temperature 
followed by extensive washing with PBST buffer for 1 hr. The slides then were subjected 
to fluorescence imaging. As results, all spaced glycopolymer microarrays showed 
enhanced lectin binding compared to non-spaced one (Fig 8). Among them, the 
polyacrylamide-BA spaced glycopolymer showed the highest enhanced lectin binding 
(Fig 8A), while BSA-BA spaced glycopolymer and lysozyme-BA spaced glycopolymer 
showed moderately enhanced lectin binding (Fig 8B and 8C). Significantly, 
glycopolymer microarrays spaced with boronic acid ligands in different sizes showed 
different levels of lectin bindings (Fig 8A, 8B, 8C). Specifically, the polyacrylamide-BA 
spaced glycopolymer showed its highest level of lectin binding with the 
glycopolymer/polyacrylamide-BA ratio of 1 to 6 (mol) (Fig 8A3), while the lysozyme-
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BA spaced glycopolymer showed its highest level of lectin binding with the 
glycopolymer/lysozyme-BA ratio of 1 to 2 (mol) (Fig 8B2), and BSA-BA spaced 
glycopolymer showed its highest lectin binding with the glycopolymer/BSA-BA ratio of 
1 to 0.6 (mol) (Fig 8C3), both of which are lower than that of polyacrylamide-BA spaced 
glycopolymer microarray (Fig 8A3). These results indicated that glycopolymer 
microarrays with different densities can be made with different boronic ligands in 
different ratios and hence revealed relevant protein bindings.  
  
Figure 8. Fluorescence images of density controlled glycopolymer microarrays spaced 
with boronic acid ligands in different molar ratios after incubation with lectin (Arachis 
hypogae (PNA), FITC-Labeled, Sigma) and their fluorescence intensities: A1-A4. 
glycopolymer spaced with polyacrylamide-BA in different ratios, B1-B4. glycopolymer 
spaced with lysozyme-BA in different ratios, C1-C4. glycopolymer spaced with BSA-BA 
in different ratios. Bar size: 500 µm. GP: glycopolymer, PA-BA: polyacrylamide-BA, 
LYZ-BA: lysozyme-BA. 
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It should be noted that both the glycopolymer and the boronic acid ligands have 
multi-binding sites and thus could afford a mixture of conjugates or form aggregates due 
to the multivalent interactions. In current study, low concentrations (mg/mL) of both 
polymers were used and no aggregates were observed.  
The spaced glycopolymer microarrays formations were reproduced with the 
highest lectin binding (Fig 9A-C). In addition, control experiments for glycopolymer 
microarray formation with unmodified lysozyme and BSA showed no enhanced lectin 
binding compared to glycopolymer alone microarray (Fig 9C1, 9C2, 9D). On the other 
hand, no glycopolymer microarray formed when the chain end O-cyanate group was 
converted to hydroxyl group in the glycopolymer
16
 (Fig 9C3 and 9C4). Overall, these 
results indicated the successful oriented and density controlled glycopolymer microarray 
formation and that the immobilized glycopolymer density had a substantial effect on its 
lectin recognition.  
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Figure 9. Fluorescence images of density controlled glycopolymer microarrays after 
incubation with lectin (Arachis hypogae, FITC-Labeled, Sigma) and their fluorescence 
intensities: A. glycopolymer spaced with polyacrylamide-BA (1:6 mol), B. glycopolymer 
spaced with lysozyme-BA (1:2 mol), C. glycopolymer spaced with BSA-BA (1:0.6 mol), 
C1. glycopolymer  treated with lysozyme (1:2 mol), C2. Glycopolymer treated with BSA 
(1:0.6 mol), C3. glycopolymer-OH, C4. glycopolymer-OH treated with polyacrylamide-
BA (1:6 mol), and D. glycopolymer alone. Bar size: 500 µm.  
Next, the oriented and density controlled glycopolymer microarrays above were 
also tested for lectin Ricinus communis (RCAI, FITC-labeled, EY Laboratories, Inc) 
binding, which recognizes β-galactose too. Interestingly, different from lectin Arachis 
hypogae bindings above, RCAI showed stronger bindings to polyacrylamide-BA spaced 
glycopolymer with the glycopolymer/polyacrylamide-BA ratio of 1 to 4 (mol) (Fig 10A2) 
and lysozyme-BA spaced glycopolymer with the glycopolymer/lysozyme-BA ratio of 1 
to 2 (mol) (Fig 10B2), and BSA-BA spaced glycopolymer showed stronger lectin binding 
with the glycopolymer/BSA-BA ratio of both 1 to 0.4 and 1 to 0.6 (mol) (Fig 10C2 and 
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10C3).  Both lectin Ricinus communis and lectin  Arachis hypogae have four binding 
sites and about 120 kDa molecular weight. However, they prefer different spacer distance 
and glycan density. This different binding preference might be due to different location 
geometry of their binding sites in the protein or the protein conformation. Overall, these 
observations indicated that arrayed glycopolymers with controlled ligand density 
facilitate optimized protein binding, which will be important for studying glycan-protein 
interaction, such as assessing multivalent glycans in parallel in a microchip format. 
  
Figure 10. Fluorescence images of density controlled glycopolymer  microarrays spaced 
with boronic acid ligands in different molar ratios after incubation of with lectin Ricinus 
communis (RCAI), FITC-labeled, EY Laboratories, Inc) and their fluorescence 
intensities: A1-A4. glycopolymer spaced with polyacrylamide-BA in different ratios, B1-
B4. glycopolymer spaced with lysozyme-BA in different ratios, C1-C4. glycopolymer 
spaced with BSA-BA in different ratios. Bar size: 500 µm. GP: glycopolymer, PA-BA: 
polyacrylamide-BA, LYZ-BA: lysozyme-BA. 
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3.3.4 Surface Plasma Resonance (SPR) assay for boronic acid ligands imprinted 
glycopolymer 
     The interaction of lectin with oriented multivalent glycans in different densities was 
also investigated with surface plasmon resonance (SPR). The major advantages of this 
assay are that it is a label free assay and monitors binding in real time. Three different 
density controlled immobilized glycopolymers were made onto CM5 chip (GE health 
science), in which the active ester NHS was first converted to amine surface by reacting 
with ethylene diamine and followed by O-cyanate-based glycopolymer immobilization 
similarly as described for glycopolymer microarray formation above. Briefly, CM5 chip 
was treated with EDC/NHS first, then with ethylene diamine in borate buffer (pH 8.5), 
followed by 1 M ethanolamine in borate buffer (pH 8.5) to quench all NHS on the chip 
surface. Once the amine modified surface is formed, glycopolymer, 
glycopolymer/lysozyme-BA, glycopolymer/polyacrylamide-BA complexes (5 mg/mL, 
NaHCO3 buffer (pH 10.3) were flowed over the chip for 7 mins at 10 µL/min and 
followed by washing with NaHCO3 buffer (pH 10.3) for 5 mins, respectively. Finally, 
flowing PBS (pH 7.4) buffer for 7 mins 10 µL/min to remove the boronic acid ligands 
afforded the oriented and density controlled glycopolymer on the SPR chip surface. 
Binding of lectin to the immobilized glycopolymers were assessed by flowing lectin 
(Arachis hypogae, Sigma) over the chip at various concentrations (0.125 nM, 0.25 nM, 
0.5 nM, 1 nM, 2 nM.) and recording the SPR sensorgrams (10 μL min−1, 25 °C). As 
shown in Figure 11, glycopolymer spaced with different boronic acid ligands showed 
different level of lectin bindings. Among them, the polyacrylamide-BA spaced 
glycopolymer showed the highest lectin binding (Fig 11A, track 3), while glycopolymer 
67 
 
alone showed the least lectin binding (Fig 11A, track 1).  These results are consistent 
with glycoarray results above (Figure 11B). These results further demonstrated that the 
density of the multivalent glycan displaying plays a critical role for enhancing their 
interactions with proteins.  
  
Figure 11. Specific binding of lectin (Arachis hypogae, FITC-labeled, Sigma) onto 
oriented and density controlled glycopolymers on SPR surface (A) and microarray (B): 1. 
Glycopolymer, 2. Glycopolymer spaced with lysozyme-BA (1:2 mol), 3. Glycopolymer 
spaced with polyacrylamide-BA (1:6 mol).  Bar size: 500 µm. 
 
3.4 Conclusion 
    We have demonstrated an oriented and density controlled glycopolymer microarray 
formation based on end-point immobilization of glycopolymer that was spaced with 
boronic acid ligands  of different sizes. Our studies confirmed that end-point immobilized 
glycopolymers with density control of both glycan in the polymer and glycopolymer on 
the microarray surface can effectively engage glycan-binding proteins and function as 
novel glycan microarray format. Lectins that bind the same glycan are affected by the 
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glycopolymer density in unique ways. The reported well-defined glycopolymer 
microarray in both orientation and glycan density can be utilized for various biological 
analyses such as profiling the glycan–protein interactions and clinical antibody detection 
and profiling, vaccine development, biomarker discovery, and drug screening 
applications.  
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CHAPTER IV 
 
IMMOBILIZED SIALYLOLIGO-MACROLIGAND AND ITS 
PROTEIN BINDING SPECIFICITY 
 
4.1 Introduction 
Sialic acids are a family of 9-carbon containing acidic monosaccharides, often 
terminate oligosaccharide structures of cell surface glycoconjugates such as glycoproteins 
and glycolipids and are involved in many biological recognition systems. For example, 
sialic acid expressed on respiratory epithelial cell surface is involved in influenza virus 
infection in both virus hemagglutinin-based attaching
1
 and neuraminidase-based 
detaching
2
 processes. The mechanisms by which influenza virus recognizes sialic acid 
have therefore been very important targets to design anti-influenza agents.
3
 To date, two 
effective neuraminidase inhibition-based anti-influenza drugs, zanamivir and oseltamivir, 
have substantially improved antiviral therapy for influenza infection.
4-5
 On the other 
hand, site-specific blocking of the viral hemagglutinin binding to host cell receptors with 
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sialic acid derivatives has been intensively investigated for antiinfluenza drug 
development.
6
  
Influenza virus contains about 350-400 HA trimers
7
 and 50 NA tetramers
8
 on its 
surface, which facilitate strong binding affinity through multivalent interactions with the 
sialic acid receptors on the host cell surface. Previous efforts using sialic acid-bearing 
macromolecules provided a proof of the concept of multivalent hemagglutinin 
inhibition.
6
 However, the monosaccharide sialic acid cannot account for the molecular 
determinant of virus receptor-binding specificity in the context of the whole 
sialyloligosaccharide receptor. Recently, it has been known that the host cell binding 
specificity and affinity of influenza viruses depend on not only sialic acid but also the 
penultimate sugar and the linkage of sialic acid to the penultimate sugar in the receptor. 
For example,  Siaα2,6Gal is indispensable receptor for the human-to-human spread of the 
influenza virus, while Siaα2,3Gal is the receptor for avian influenza virus infection.9-10 
Therefore, sialyoligosaccharide is likely the choice as an active ligand for specific and 
stronger influenza HA binding and thereby a multivalent sialyloligosaccharide would be 
rational influenza HA inhibitors. During the past decade, several sialyloligosaccharide-
containing macromolecules have been demonstrated to inhibit influenza virus attachment 
to target cells and suppress the virus-mediated hemagglutination and neutralize virus 
infectivity in cell culture.
11 
 
Glycopolymers, namely polymers with carbohydrate pendent groups, have been 
extensively explored for different biological and biomedical applications.
12-13 
It is 
generally accepted that glycopolymers can mimic the functions of naturally occurring 
glycoconjugates
14-15 
and have been employed as cell-surface binding receptors.
16
 The 
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strength and selectivity of binding interactions between multivalently displayed 
carbohydrates and targets are likely to depend on the density and relative spatial 
arrangement of the carbohydrate residues on the glycopolymers. Recently, the potential 
utility of glycopolymers in bio- and immunochemical assays as biocapture reagents and 
for microarray applications have been demonstrated by adding functional anchor group 
either as a pendant to the polymer backbone or at the chain end.
17
 Particularly, the chain-
end groups of glycopolymers are the focus for bio-functionalization, as they allow for a 
direct one-to-one attachment
18-19 
and also facilitate site specific
20 
 and oriented 
immobilization on solid surfaces.
21
 This molecular recognition pattern is especially 
exploited on solid surfaces for the development of biosensors, chip-based bioassays, and 
cell-adhesion studies
22
 as they mimic the three dimensional (3D) display of glycans on 
the cell surface. Recently, Bertozzi’s group23 and our group24 reported oriented 
glycopolymer microarrays based on end-point immobilization of glycopolymers to mimic 
3D natural cell surface glycan displaying. In these approaches, the densities and 
orientations of the glycan ligands are determined by the polymer structure rather than by 
features of the underlying microarray surface. These parameters should therefore be more 
controllable than in the case with conventional 2D glycan microarrays. In our previous 
study, O-cyanate chain-end functionalized glycopolymer provides an anchor for site-
specific and covalent immobilization of the glycopolymer onto an amine surface via 
isourea bond formation and thereby facilitates an oriented glyco-macroligand 
formation.
24
 Herein, we report a chemoenzymetic synthesis of O-cyanate chain-end 
functionalized sialyllactose-containing glycopolymers and their oriented sialyloligo-
marcroligand formation for glycoarray and glyco-biosensor applications (Fig 1). 
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Particularly, O-cyanate chain-end functionalized sialyllactose-containing glycopolymer 
was immobilized onto amine-modified glass slide and SPR chip via isourea bond 
formation, respectively. This oriented sialyloligo-macroligand microarray and SPR-based 
glyco-biosensor platform are expected to facilitate both affinity and specificity of protein 
binding and thus will provide a versatile tool for profiling glycan recognition for both 
basic biological research and practical applications. 
 
 
Figure 1. Chemical structure of O-cyanate chain-end functionalized sialyllactose-
containing glycopolymers and their oriented immobilization via isourea bond formation 
for microarray and SPR applications. 
 
4.2 Experimental  
4.2.1 Materials and methods 
All solvents and reagents were purchased from commercial sources and were used as 
received, unless otherwise noted. CMP-Neu5Ac, α2,3-sialyltransferase and α2,6-
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sialyltransferase were purchased from Sigma. FITC-labeled MAA (Macckia amurensi) 
and SNA (Sambucus nigra) were purchased from Bioworld (Dublin, OH). Avain HA 
(A/Anhui/1/2005(H5N1)) and human HA (A/Brisbane/10/2007(H3N2)) were purchased 
from Sino Biological (China). O-Cyanate chain-end functionalized lactose-containing 
glycopolymer was synthesized as previously reported.
24 
 
4.2.2 Enzymatic synthesis of sialyllactose glycopolymers (SGPs) 
 O-Cyanate chain-end functionalized lactose-containing glycopolymer (40 mg, 1 µmole, 
10 µmoles of lactose) was dissolved in 2 mL of buffer [Triton X-100 (0.5%) + HEPES 
(0.10 M) + MgCl2 (5 mM) + MnCl2 (2 mM) + ZnCl2 (5 x 10
-5
 M), pH 7.4]. To the 
dissolved polymer, CMP-Neu5Ac (6.5 mg, 100 µmoles), calf alkaline phosphate (10 U), 
bovine serum albumin (0.8 mg), and α2,3-sialyltransferase (0.5 U) were added and the 
mixture was stirred gently at room temperature for two days (48 hrs). The resultant α2,3-
sialyllacotose glycopolymer (α2,3SGP) was purified by gel-filtration with Sephadex G-
25 column (eluted with water) and the fractions containing SGP were confirmed with 
phenol sulfuric acid assay. The same protocol was employed to synthesize α2,6-
sialyllacotose glycopolymer (α2,6SGP) by using α2,6-sialyltransferase, the O-cyanate 
chain-end functionalized lactose-containing glycopolymer and CMP-Neu5Ac. The 
resultant SGPs were characterized by 
1
H NMR spectrometry. 
α2,6SGP ( 4): Molecular Weight: 17,600 (determined by 1H NMR) ; 1H NMR (D2O, 400 
MHz) δ(ppm): 7.21, 7.06 (H of phenyl), 4.36, 4.33 (H1 of Gal and H1 of Glc), 3.85-3.36 
(H of Gal and Glc), 3.28-3.20 (H of -OCH2CH2O-, linker), 2.56 (H3eq of Neu5Ac), 2.20-
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1.94 (-CH- of polymer backbone), 1.89 (CH3 of Neu5Ac), 1.70-1.30 (-CH2- of polymer 
backbone). 
α2,6SGP (5): Molecular Weight: 17,600 (determined by 1H NMR); 1H NMR 
(D2O, 400 MHz) δ(ppm): 7.20, 7.04 (H of phenyl), 4.36, 4.33 (H1 of Gal and H1 of Glc), 
3.95-3.40 (H of Gal and Glc), 3.28-3.18 (H of -OCH2CH2O-, linker), 2.60 (H3eq of 
Neu5Ac), 2.20-1.94 (-CH- of polymer backbone), 1.89 (CH3 of Neu5Ac), 1.70-1.30 (-
CH2- of polymer backbone). 
 
4.2.3 Sialyllactose glycopolymer microarray fabrication 
MicroCaster microarray tool (Whatman, spot size 500 µm diameter) was inked with a 
solution of α2,3SGP in NaHCO3 buffer (pH 10.3,  2.1 x 10
-2  
mM), then was pressed onto 
amine functionalized glass slides (Xenopore, Co) at room temperature for 10 min. The 
glass slides were then incubated in a humidifier chamber at 37 
o
C for 4 h and then 
washed with NaHCO3 buffer (pH 10.3) (30 min, 3 times) and followed by washing with 
0.2% PBST buffer (pH7.4). Then the array glass slides were incubated with lectin MAA-
FITC (Macckia amurensis, 1.4 x 10
-3
 mM, Bioworld) in 0.2% PBST buffer (pH 7.4) at 
room temperature for 3 h and followed by extensive washing with 0.2% PBST buffer (pH 
7.4) for 30 min and finally subjected to fluorescent imaging. As control experiments, the 
α2,3SGP printed glass slides were incubated with lectin SNA-FITC (Sambucus nigra,1.3 
x 10
-3 
mM,  Bioworld), PNA-FITC (Arachis hypogaea, 1.6 x 10
-3
 mM, Sigma), MAA-
FITC (0.2 mg, 1.4 x 10
-3
 mM,  Bioworld) that was pre-incubated with α2,3-sialyllactose 
(1.5 x 10
-2 
mM, V-Labs), α2,6-sialyllactose (1.5 x 10-2 mM,  V-Labs) and free sialic acid 
(3.2 x 10
-2 
mM, Rose Scientific ltd ) in 0.2% PBST buffer (pH 7.4) at room temperature 
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for 2 h, respectively, and followed by extensive washing with 0.2% PBST buffer (pH 7.4) 
for 30 min and finally subjected to fluorescent imaging, respectively.  
The same protocol was used for α2,6SGP microarray fabrication and followed by 
incubation with lectin SNA-FITC (1.3 x 10
-3 mM). As control experiments, the α2,6SGP  
printed glass slides were incubated with lectin MAA-FITC (1.3 x 10
-3 
mM), lectin SNA-
FITC (1.4 x 10
-3 
mM) that was pre-incubated with α2,6-sialyllactose (1.5 x 10-2 mM), 
α2,3-sialyllactose (1.5 x 10-2 mM) and free sialic acid (3.2 x 10-2 mM), PNA-FITC 
(Arachis hypogaea, 1.6 x 10
-3
 mM, Sigma)  in 0.2% PBST buffer (pH 7.4) at room 
temperature for 2 h, respectively, and followed by extensive washing with 0.2% PBST 
buffer (pH 7.4) for 30 min and finally subjected to fluorescent imaging, respectively. 
 
4.2.4 SPR analysis of specific MAA and SNA binding to immobilized α2,3SPG and 
α2,6SGP 
The specific binding of lectin to immobilized SGP was analyzed with SPR with a BI 
2000 biosensor system (BI Biosensing Instruments). To prepare the sensing surface, the 
commercial SPR gold chip (BI Biosensing Instuments) was rinsed with piranha solution 
of sulfuric acid and hydrogen peroxide (1:1, v/v), followed by water and ethanol (3 times) 
and dried under nitrogen. The dried gold chip was incubated with 1 mg/mL of cystamine 
solution in ethanol at 4 ˚C overnight and followed by washing with ethanol and water to 
remove weakly adsorbed cystamine to generate amine functionalized gold chip surface. 
Next, α2,3SGP was covalently immobilized onto the amine functionalized gold chip 
surface by flowing the polymer solution (2 mg/mL, NaHCO3 buffer (pH 10.3)) at a flow 
rate of 10 µL/min for 600 sec and repeated at least 3 times until the surface is saturated 
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with the polymer, NaHCO3 buffer (pH 10.3) was used as a running buffer. Then a serial 
of solution of lection MAA in concentration ranging from 0.5 µM to 10 µM in PBS 
running buffer (pH 7.4) were injected over the immobilized α2,3SGP at a flow rate of 20 
µL/min for 2 min (120 sec, association phase). For regeneration of the surface, 0.1 M 
HCl (pH 1.5) was injected at a flow rate of 20 µL/min for about 30 sec and sometimes 
repeated twice to remove bound lectin completely. The association and dissociation 
constants of the lectin binding to immobilized SGP were determined by standard BI 2000 
(scrubber) evaluation software. For the experiments with α2,6SGP, the same surface 
modification procedure was followed as above. For lectin SNA binding, the same 
procedure was used as above except different concentrations ranging from 1 µM to 10 
µM used. 
 
4.2.5 Competitive binding assay of lectin to immobilized SGP 
 Both α2,3SGP and α2,6SGP were immobilized on the gold sensor chip by following the 
same procedure as above. Solutions of MAA and SNA were prepared in PBS buffer (pH 
7.4, 10 µM) and were pre-incubated with a series of α2,3-sialyllactose and α2,6-
sialyllactose in concentrations ranging from 0.075 nM to 7.5 nM, respectively. As 
control, MAA and SNA (10 µM) were pre-incubated with high concentration (7.5 nM) of 
2,6-sialyllactose and 2,3-sialyllactose, respectively. These pre-incubated MAA and SNA 
were injected over the immobilized α 2,3SGP and α2,6SGP at a flow rate of 20 µL/min 
for 3 min (180 sec, association phase), respectively. For regeneration of the surface, 0.1 
M HCl (pH1.5) was injected at a flow rate of 20 µL/min for 30 sec. The response of the 
binding was calculated by standard BI 2000 (scrubber) evaluation software. 
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4.2.6 Hemagglutintin (HA) binding to immobilized SGP 
Both α2,3SGP and α2,6SGP were immobilized on the gold sensor chip following the 
same procedure as above. Solutions of H5N1 HA (A/Anhui/1/2005(H5N1)) and H3N2 
HA (A/Brisbane/10/2007(H3N2)) (Sino Biological, China) were prepared in PBS buffer 
(pH 7.4 pH, 420 nM), then were injected over the two immobilized α2,3SGP and 
α2,6SGP at a flow rate of 20 µL/min for 180 sec, respectively. As control, both H5N1 
HA and H3N2 HA were pre-incubated with α2,3-sialyllactose (PBS buffer (pH 7.4), 5 x 
10
-6 mM) and α2,6-sialyllactose (PBS buffer (pH 7.4), 5 x 10-6 mM) for 30 min, and then 
injected over immobilized α2,3SGP and α2,6SGP, respectively. 100 mM NaOH was 
injected for regeneration of surface between each HA injections. The association and 
dissociation constants of the protein to immobilized SGP were determined by standard BI 
2000 (scrubber) evaluation software. 
 
4.3 Results and Discussion 
4.3.1 Synthesis and characterization of O-cyanate chain-end functionalized 
sialyllactose glycopolymers 
     Recently, a variety of methods have been developed for the synthesis of  chain-end 
functionalized glycopolymers for potential biomedical applications such as protein 
modification and microarray fabrication applications.
17
 We have demonstrated that 
cyanoxyl mediated free-radical polymerization is a straightforward approach to 
synthesize O-cyanate chain-end functionalized glycopolymer that could be immobilized 
onto amine functionalized silica gel beads via isourea bond formation and amine 
functionalized glass slide for oriented glycopolymer microarray fabrication 
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applications.
24 
Particularly, the polymerization could be conducted in aqueous solution, 
tolerant of a broad range of functional groups including -OH, -NH2, -COOH, and SO3
-
 
moieties, and yield glycopolymers with low polydispersity (PDI < 1.5). In this study, an 
O-cyanate chain-end functionalized lactose-containing glycopolymer (3) was synthesized 
as described in our previous report,
24
 and then enzymatic sialylation of the terminal 
galactose (Gal) pending on the polymer was investigated for synthesizing O-cyanate 
chain-end functionalized silallylactose-containing glycopolymer. The enzymatic 
approach for transferring sialic acid from CMP-Neu5Ac to the non-reducing end of the 
carbohydrate acceptor was extensively reported.
25
 The glycosidic linkage between the 
sialic acid and the acceptor carbohydrate is extremely controlled by the type of 
sialyltranferase selected. The transfer of sialic acid residue from CMP-Neu5Ac to 3- and 
6-positions of terminal Gal of lactose glycopolymer (3), by enzymes α2,3-
sialyltransferase and α2,6-sialyltransferase afforded silallylactose-containing 
glycopolymer α2,6SGP (4) and α2,3SGP (5), respectively (Scheme 1). The resultant 
SGPs were characterized by 
1
H NMR spectra. The successful sialyation of lactose 
glycopolymer was confirmed by the signals of protons from Neu5Ac (1.95 ppm, CH3-
Neu5NAc and 2.60 ppm, H3eq-Neu5Ac), the degree of sialyation and the polymer length 
as well were calculated also using the 
1
HMR spectra by comparing the integration value 
of proton signals from aromatic protons (7.21 ppm and 7.06 ppm), anomeric protons 
(4.36 ppm and 4.33 ppm) of Gal and Glc, and C3-equatorial proton (2.60 pm) of Neu5Ac 
as shown in Figure 2. By comparing the integrated signal from the anomeric protons of 
Gal and Glc (4.36 ppm and 4.43 ppm,) with that of the C3-equatorial proton of Neu5Ac 
(2.60 ppm, H3eq-Neu5Ac), the percentages of both sialyalations were more than 90%. 
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Scheme 1. Chemoenzymatic synthesis of O-cyanate chain-end functionalized 
sialyllactose-containing glycopolymers via cyanoxyl mediated free radical 
polymerization followed by enzymatic sialylation. 
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Figure 2. 
1
H NMR spectra of glycopolymers in D2O: A. lactose glycopolymer (3), B. 
α2,6-sialyllactose glycopolymer (4), C. α2,3-sialyllactose glycopolymer (5). 
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4.3.2 SGP Microarray fabrication and its specific lectin binding 
     SGP-based microarrays were fabricated by printing O-cyanate chain-end SGP onto 
amine functionalized glass slide. Briefly, α2,3SGP and α2,6SGP were printed (sport size 
500 µm diameter) on amine functionalized glass slides (Xenopore Co) with MicroCaster 
in NaHCO3 buffer (pH 10.3).  The glass slides were incubated in humidifying chamber at 
37
o
C for 4 h and then washed with NaHCO3 buffer and followed by washing with PBS 
buffer (pH 7.4) containing 0.2% tween 20 (PBST) in order to minimize nonspecific 
binding of proteins onto the glass surface later. Next, the specific lectin binding ability of 
the SGP-based microarray was performed. The resultant α2,3SGP and α2,6SGP printed 
glass slides were incubated with respective FITC-labeled lectins, Macckia amurenisis 
(MAA) and Sambucus nigra (SNA) (Bioworld) in PBST buffer (pH 7.4) followed by 
extensive washing with PBST buffer (pH 7.4) and finally the glass slides were subjected 
to fluorescent imaging, respectively. Lectin MAA that has affinity for α2,3-linked sialic 
acid showed binding to α2,3SGP (Fig 3Ia), while lectin SNA which has affinity for α2,6-
linked sialic acid showed no binding to α2,3SGP (Fig 3Ib). To confirm the specific 
binding, competitive inhibition assays were performed as by incubating the α2,3SGP 
arrayed glass slides with lectin MAA that was pre-incubated with α2,6-siallylactose, 
α2,3-siallylactose and free sialic acid, respectively. As a result, MAA pre-incubated with 
α2,3-sialyllactose showed no binding to α2,3SGP (Fig 3Id), while MAA pre-incubated 
with α2,6-siallylactose and free sialic acid still showed lectin binding to α2,3SGP (Fig 
3Ic and 3Id). On the other hand, lectin MAA showed no binding to α2,6SGP (Fig 3IIa), 
while lectin SNA showed binding to α2,6SGP (Fig 3IIb). Same pattern of inhibition 
assays were performed by incubating α2,6SGP arrayed glass slides with SNA that was 
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pre-incubated with α2,6-sialyllactose, α2,3-sialyllactose and free sialic acid, respectively. 
As a result, SNA pre-incubated with α2,6-sialyllactose showed no binding to α2,6SGP 
(Fig 3IIc), while SNA PI with α2,3-siallylactose and free sialic acid still showed lectin 
binding to α2,6SGP (Fig 3IId and 3IIe). In addition, in order to determine the quantitative 
sialyation of lactose glycopolymer (3), both α2,3SGP and α2,6SGP printed glass slides 
were incubated with lectin PNA that has specificity to α-galactose on the starting 
glycopolymer (3). As a result, no apparent PNA binding was observed for both α2,3SGP 
and α2,6SGP printed glass slides (Fig 3If and 3IIf), which indicated that there were no 
lactose left on the glycopolymer after enzymatic sialylation.  Overall, these observations 
indicate that arrayed SGPs are capable of distinguishing different glycan-binding protein 
based on their sialic acid linkage to the galactose in the SGPs.  
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Figure 3. Fluorescence images of α2,3SGP and α2,6SGP microarrays: I. α2,3SGP array 
incubated with FITC-labeled lectin, a. MAA, b. SNA, c. MAA pre-incubated with α2,6-
sialyllactose (α2,6SL), d. MAA pre-incubated with α2,3-sialyllactose (α2,3SL), e. MAA 
pre-incubated with free sialic acid (SA), and f. PNA; II. α2,6SGP array incubated with 
FITC-labeled lectin, a. MAA, b. SNA, c. SNA pre-incubated with α2,6SL, d. SNA pre-
incubated with α2,3SL, e. SNA pre-incubated free SA, and  f. PNA. Bar size: 500 µm. 
[MAA: Macckia amurensis, SNA: Sambucus nigra, PNA: Arachis hypogaea] 
 
 
4.3.3 Surface Plasmon Resonance (SPR) analysis of lectin binding to immobilized SGP 
     The interaction of lectin with oriented immobilized SGPs was also investigated with 
SPR (BI 2000, Biosensing Instrument). The major advantages of SPR assay are that it is a 
label free assay and monitors the binding in real time. Initially, the gold sensor chip was 
functionalized with amine by treating the sensor chip with cysteamine in ethanol 
overnight, the monolayer formation on the sensor chip was confirmed by increase in the 
resonance units upon modification of the chip (data not shown). Next, α2,3SP was 
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covalently immobilized onto the amine modified sensor chip at a flow rate of 5 μL/min in 
NaHCO3 buffer (pH 10.3) in flow cell one for 10 min while the flow cell two was used a 
control to subtract the non-specific binding to the surface. Glycopolymer immobilization 
was repeated until there is no further immobilization observed at fourth time (Fig 4A1-4). 
Then, a various concentrations of MAA in PBS buffer (pH 7.4) were injected over the 
α2,3SGP modified sensor chip at a flow rate of 20 μL/min for 2 min. A typical 
sensogram was obtained as increased binding of lectin to the SGP was observed with 
increasing lectin concentration (Fig 5A and 5A1). In contrast, only a negligible binding 
was observed when lectin SNA was injected over α2,3SGP (Fig 6A2), verifying the 
specific binding of SGP to its specific lectin. Similar experiments were performed with 
α2,6SGP immobilization onto the chip surface (Fig 4B1-4) and its lectin binding 
monitored by SPR. As a result, specific SNA binding to immobilized α2,6SGP was 
observed as shown in Figure 5B, 5B1 and Figure 6A1, while a negligible binding was 
observed when lectin MAA was injected over α2,6SGP (Fig 6B2). The dissociation 
constant (kd) values for MAA and SNA for their respective SGP were determined. 
Interestingly, MAA and SNA have similar association constant (ka) values for α2,3SGP 
and α2,6SGP, respectively (Table 1). However, the kd were relatively different, the kd of 
SNA from α2,6 SGP was observed to be almost 14 fold higher than that  of MAA from 
α2,3SGP. This indicated that the binding of MAA to α2,3SGP is stronger when compared 
to that of SNA to α2,6SGP.  
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Figure 4. SPR sensorgrams of SGP immobilization: A. α2,3SGP immobilization, B. 
α2,6SGP immobilization. 1. First Injection, 2. Second injection, 3. Third injection, 4. 
Fourth injection.  
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Figure 5. SPR sensorgrams of lectin binding onto SGP: A. different concentrations of 
MAA binding to α2,3SGP; A1. Steady state binding response of MAA to α2,3SGP; B. 
different concentrations of SNA binding to α2,6SGP; B1. Steady state binding response 
of SNA to α2,6SGP.  
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 Figure 6. SPR sensorgrams of lectin SNA (A) and MAA (B) binding to SGP: A1. SNA 
(5 µM) binding to immobilized α2,6SGP; A2. SNA binding to immobilized α2,3SGP; 
B1. MAA (5µM) binding to immobilized α2,3SGP; B2. MAA binding to immobilized 
α2,6SGP. 
     Table 1. Binding kinetics of lectins to immobilized SGPs in SPR assays 
Glycopolymer Lectin ka (M
-1
s
-1
) kd  (s
-1
) KD (M) 
α2,3SGP MAA 4.39 x 103 9.08 x 10-4 2.06 x 10-7 
α2,6SGP SNA 4.69 x 103 1.25 x 10-2 2.60  x 10-6 
 
 
4.3.4 Competitive binding assay of lectin to immobilized SGP 
     Next, competitive binding assays were conducted to confirm the specific lectin 
binding to immobilized SGP by pre-incubating the lectin with free ligands. Briefly, the 
SGP were immobilized onto SPR chip as described above. The lectin was pre-incubated 
with different concentrations of sialyllactose (α2,3SL for MAA and α2,6SL for SNA) in 
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PBS buffer (pH 7.4) for 30 min before injecting over the immobilized SGP. It was 
observed that by increasing the concentration of sialyllactose (from 0.75 nM to 7.5 nM) 
the binding of lectin to immobilized SGP is reduced significantly as shown in Figure 
7Aa-b for α2,3SGP and Figure 7Ba-b for α2,6SGP, whereas when the lectins were pre-
incubated with non specific sialyllactose i.e. MAA with α2,6SL (Fig 7A-e) and SNA with 
α2,3SL (Fig 7B-e), there was no inhibition observed. Even in higher concentration of 7.5 
nM, there is no inhibition in lectin binding to their corresponding SGP when compared to 
the lectins pre-incubated with specific sialyllactose (Fig 7A1and B1). This was due to the 
fact that sialyllactoses saturate the binding sites of the lectin, causing its reduced binding 
to the immobilized SGP and so further confirms the fact that the α2,3SGP and α2,6SGP 
show specifically binding activity to their corresponding protein, respectively. 
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Figure 7. SPR sensorgrams of lectin binding to SGP: A. Lectin binding to α2,3SGP, 
MAA pre-incubated with α2,3SL in concentration of a. 0.075 nM, b. 0.15 nM, c. 0.25 
nM, d. 0.75 nM, e. MAA pre-incubated with 0.75 nM of α2,6SL; A1. Steady state 
response of lectin binding to α2,3SGP; B. Lectin binding to α 2,6SGP, SNA pre-
incubated with α2,6SL in concentration of a. 0.075 nM, b. 0.15 nM, c. 0.25 nM, d 0.75 
nM, e. SNA pre-incubated with 0.75 nM of α2,3SL; B1. Steady state response of lectin 
binding to α2,6SGP.  
 
 
93 
 
4.3.5 Hemagglutinin binding to immobilized SGP monitored by SPR 
     With the binding specificity confirmed for immobilized SGPs, we next examined their 
specific binding to influenza viral hemagglutinins (HAs) of avian H5N1 
(A/Anhui/1/2005(H5N1)) and human H3N2 (A/Brisbane/10/2007(H3N2)) with SPR 
technique, which bind to α2,3SGP and α2,6SGP, respectively. Human and avian HA in 
PBS buffer (pH 7.4) were injected over immobilized α2,3SGP and α2,6SGP, 
respectively. As a result, avian HA showed stronger binding (response units) to α2,3SGP 
(Fig 8Aa) than α2,6SGP (Fig 8Bd), and avian HA binds to α2,3SGP much stronger so 
that there is no dissociation observed from α2,3SGP (Table 2). Also, when avian HA was 
pre-incubated with both α2,6-sialylactose and α2,3-sialylactose, the binding affinity of 
HA decreased rapidly compared to HA alone (Fig 8Ab, 8Ac), however, the dissociation 
of avian HA pre-incubated with α2,3-sialylactose was 2 fold higher than that of avian HA 
pre-incubated with α2,6-sialylactose (Table 2) indicating that avian HA binds strongly to 
α2,3-linked sialic acid. On the other hand, human HA showed higher binding (response 
units) to α2,6SGP (Fig 8Ba) than α2,3SGP (Fig 8Ad), the dissociation of human HA 
from α2,3SGP is 25 fold higher than that from α2,6SGP (Table 2), indicating that human 
HA detached more rapidly from α2,3SGP and binds strongly to α2,6SGP. When human 
HA was pre-incubated with both α2,6-sialylactose and α2,3-sialylactose, the binding 
affinity of human HA decreased rapidly compared to human HA alone (Fig 8Bb, 8Bc), 
however, the dissociation of human HA pre-incubated with 2,6-sialylactose was 5 fold 
higher than that of human HA pre-incubated with α2,3-sialylactose (Table 2) indicating 
that human HA binds strongly to α2,6-linked sialic acid. Overall, these observations 
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indicated that avian influenza virus HA has higher affinity to α2,3-linked sialic acid and 
human virus to α2,6-linked sialic acid of the immobilized SGP. 
 
 
Figure 8. SPR sensorgrams of HA binding to SGP: A. HA binding to α2,3SGP, a. avian 
HA, b. avian HA pre-incubated with α2,6SL, c. avian HA pre-incubated with α2,3SL, d. 
human HA; A1. Steady state response of HA binding to α2,3SGP; B. HA binding to 
α2,6SGP, a. human HA, b. human HA pre-incubated with α2,6SL, c. human HA pre-
incubated with α2,3SL, d. avian HA; B1. Steady state response of HA binding to 
α2,6SGP.  
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Table 2. HA binding to immobilized SGP monitored by SPR 
Glycopolymer HA type kd (s
-1
) Response (RU) 
α2,3SGP H5N1 nd 307.2 
 H5N1 + α2,3SL 6.5 x 10-3 212.4 
 H5N1 + α2,6SL 3.7 x 10-3 69.84 
 H3N2 1 x 10
- 3 
138.2 
α2,6SGP H3N2 4 x 10-5 502.2 
 H3N2 + α2,3SL 2 x 10-4 100.4 
 H3N2 + α2,6SL 7 x 10-4 135.1 
 H5N1 6 x 10
-5 
286.3 
(nd: not detectable) 
 
4.4 Conclusion 
     A chemoenzymatic synthesis of O-cyanate chain-end functionalized sialyllactose-
containing glycopolymers was developed via one-pot cyanoxyl mediated free radical 
polymerization followed by enzymatic sialylation. The chain-end O-cyanate group of the 
polymer provides an anchor for oriented and covalent immobilization of the 
glycopolymer onto amine surface via isourea bond formation in mild condition, which 
were used for glycoarray and biosensor applications. The specific binding activity of the 
arrays were confirmed with α2,3- and α2,6-sialyl binding lectin together with inhibition 
assays. Further, SPR-based glyco-sensor showed specific binding activity for lectins and 
influenza hemagglutins (HA) as well. These oriented sialyloligo-macroligand derived 
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glycoarray and SPR-based glyco-sensor are closely to mimic 3D nature presentation of 
sialyloligosaccharides and will provide important high-throughput tools for virus 
diagnosis and potential anti-viral drug candidates screening applications. In addition, the 
chain-end functionalizable glycopolymers can be used for polymer-protein conjugation as 
well.  
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CHAPTER V 
 
SUMMARY 
 
 
     As carbohydrates present on the cell surfaces act as biomolecular recognition markers 
for a variety of important biological functions, including cell communications, cell 
adhesion, fertilization, differentiation and immune response through specific interactions 
with proteins, it is essential to carefully choose carbohydrate epitopes and study the 
carbohydrate-protein interactions. Glycans structured into multivalent ligands in the form 
of linear polymers, have potential microarray application to study the carbohydrate 
binding molecules. Also the low affinity and specificity which is typical for monomeric 
carbohydrate-protein interactions are noticeably enhanced when carbohydrate 
components are present as multivalent ligands like glycopolymers. Besides  carbohydrate 
microarrays processes a wide variety of potential applications in glycomics including 
rapid determination of binding profile of carbohydrate-binding proteins, detection of 
specific antibodies for disease diagnosis, characterization of carbohydrate-cell 
recognition events and the high-throughput screening of inhibitors to prevent 
carbohydrate-protein interactions. On the other hand surface Plasmon resonance 
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technique has several advantages in studying the bio-molecular interaction in real-time 
with a minute amount of label free samples. 
     In this thesis study, oriented and multivalent glycomacroligands were designed and 
developed based on a chain-end functionalized carbohydrate-containing polymer 
(glycopolymer) for efficient proteomic applications.  
     First, the O-cyanate chain-end functionalized glycopolymer was synthesized via one-
pot cyanoxyl mediated free radical polymerization technique and there is no protection 
and deprotection steps needed and thus is a straightforward approach. The chain-end O-
cyanate group of the polymer provides an anchor for site-specific and covalent 
immobilization of the glycopolymer onto any amine surface via isourea bond formation 
in mild condition. An oriented glyco-marcroligand formation based on O-cyanate chain-
end functionalized glycopolymer with commercially available amine modified silica gel 
and glass slide via isourea bond formation was demonstrated, respectively. 
     Second, an oriented and density controlled glyco-marcroligand array formation was 
demonstrated by end-point immobilization of glycopolymer imprinted with boronic acid 
ligands in different sizes. Briefly, O-cyanate chain-end functionalized glycopolymer was 
pre-modified by phenylboronic acid-lysozyme, BSA and polyacrylamide ligands and then 
immobilized onto amine-functionalized glass slide via isourea bond formation at pH 10.3, 
followed by releasing the phenylboronic acid ligands at pH 7.4, respectively. Glycoarray 
and SPR results confirmed the same trend of density-dependent binding of lectins. 
Imprinted glyco-marcroligand showed more lecting binding than non-imprinted one, and 
the phenylboronic acid-polyacrylamide imprinted glyco-marcroligand showed highest 
lectin binding.  
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     Third, a chemoenzymatic synthesis of O-cyanate chain-end functionalized 
sialyllactose-containing glycopolymers was developed via one-pot cyanoxyl mediated 
free radical polymerization followed by enzymatic sialylation. The chain-end O-cyanate 
group of the polymer provides an anchor for oriented and covalent immobilization of the 
glycopolymer onto amine surface via isourea bond formation in mild condition, which 
were used for glycoarray and biosensor applications. The specific binding activity of the 
arrays were confirmed with α2,3- and α2,6-sialyl binding lectin together with inhibition 
assays. Further, SPR-based glyco-sensor showed specific binding activity for lectins and 
influenza hemagglutins (HA) as well. 
     The orientally immobilized multivalent glyco-macroligands could be used for will 
provide important high-throughput tools for virus diagnosis and potential anti-viral drug 
candidates screening applications. In addition, the chain-end functionalizable 
glycopolymers can be used for polymer-protein conjugation as well.  
.  
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CHAPTER VI 
 
FUTURE PERSPECTIVES 
 
 
     Overall, in this study, oriented multivalent glycopolymer has been developed and 
could be used to study carbohydrate-protein interactions and thus are expected to 
constitute a core strategy of rapidly and sensitively identifying carbohydrate binding 
proteins. Also the immobilized sialyated glycopolymer was used to study the binding 
affinities of both avian and human influenza viral recombinant hemagglutinin proteins. In 
future, the potential of the oriented glyco-macroligad for analyzing influenza viral 
hemagglutinin should be investigated by mass spectrometry technique. Mass 
spectrometry has served an important role in the characterization of a range of viral and 
bacterial pathogens over several decades.
1-6
 It has been recruited to characterize viral 
proteins,
7-9 
their posttranslational modifications
10
 from disulphide bonds to 
glycosylation
11-12
 follow mutations in these proteins
13
 that result from replication errors 
or the trading of genetic material from one strain to another, and assess viral structure 
through studies of protein interactions and assemblies
14-16
 and the binding of antiviral 
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drugs.
17
 Mass spectrometry offers advantages for characterizing the influenza virus in 
terms of its genetic character, viral protein character, antigenicity, and for the quantitation 
of viral proteins and antiviral drugs.
18
 
In future, both α,2-3 and α,2-6 linked sialylglycopolymers will be immobilized 
onto silica gel for HA and its proteolysis product isolation. For this study HA will be 
digested and followed by isolation with oriented glyco-macroligand on silica gel and 
subsequent mass spectrometry analysis so as to seek the sialic acid-binding residue, 
conserved residue and peptide segments that can be used to subtype the influenza virus. 
On the other hand, proteolysis of whole virus or gel-recovered influenza antigens
19-20
 
combined with mass spectrometry provides a means with which to investigate these 
proteins and subtype strains where the hemagglutinin surface antigens will be studied. 
With the efficient influenza virus capture surfaces with receptor selectivity established 
above, rapid isolation and identification of real influenza virus will be conducted. 
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